|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4609546A
(en)
|
1982-06-24 |
1986-09-02 |
Japan Chemical Research Co., Ltd. |
Long-acting composition
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
JPH01207920A
(ja)
|
1988-02-16 |
1989-08-21 |
Oki Electric Ind Co Ltd |
ＩｎＰ半導体薄膜の製造方法
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5270202A
(en)
|
1989-11-03 |
1993-12-14 |
Syamal Raychaudhuri |
Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
|
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
IE911869A1
(en)
|
1990-06-01 |
1991-12-04 |
Regeneron Pharma |
A family of map2 protein kinases
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5780587A
(en)
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
|
WO1993006116A1
(en)
|
1991-09-20 |
1993-04-01 |
Syntex-Synergen Neuroscience Joint Venture |
Glial derived neurotrophic factor
|
|
US5412087A
(en)
|
1992-04-24 |
1995-05-02 |
Affymax Technologies N.V. |
Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
|
|
DE69233528T2
(de)
|
1991-11-25 |
2006-03-16 |
Enzon, Inc. |
Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
|
|
WO1993011231A1
(en)
|
1991-12-06 |
1993-06-10 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Tools for the diagnosis and treatment of alzheimer's disease
|
|
US5624807A
(en)
|
1992-07-22 |
1997-04-29 |
The Mclean Hospital Corporation |
Methods for detecting Alzheimer's disease by measuring ratios of calcium-activated neutral protease isoforms
|
|
ATE199392T1
(de)
|
1992-12-04 |
2001-03-15 |
Medical Res Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
AU6445894A
(en)
|
1993-03-19 |
1994-10-11 |
Duke University |
Method of treatment of tumors with an antibody binding to tenascin
|
|
AU683703B2
(en)
|
1993-10-20 |
1997-11-20 |
Duke University |
Method of binding material to the beta-amyloid peptide
|
|
US5985660A
(en)
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
|
CU22615A1
(es)
|
1994-06-30 |
2000-02-10 |
Centro Inmunologia Molecular |
Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
|
|
AU3272695A
(en)
|
1994-08-12 |
1996-03-07 |
Immunomedics Inc. |
Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
|
|
EP0783523B1
(en)
|
1994-08-26 |
2004-10-20 |
Human Genome Sciences, Inc. |
Gaba a receptor epsilon subunit
|
|
DE69535901D1
(de)
|
1994-10-28 |
2009-01-29 |
Max Planck Gesellschaft |
Proteinkinase npk-110
|
|
US6835555B1
(en)
|
1994-11-01 |
2004-12-28 |
Human Genome Sciences, Inc. |
Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
|
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
DE4447287C1
(de)
|
1994-12-30 |
1996-11-07 |
Cevc Gregor |
Präparat zum Wirkstofftransport durch Barrieren
|
|
US5650313A
(en)
|
1995-06-05 |
1997-07-22 |
Human Genome Sciences, Inc. |
Ubiquitin conjugating enzymes 8 and 9
|
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
|
GB9506197D0
(en)
|
1995-03-27 |
1995-05-17 |
Hoffmann La Roche |
Inhibition of tau-tau association.
|
|
US6576607B1
(en)
|
1995-04-19 |
2003-06-10 |
Acorda Therapeutics |
Methods using CNS neurite outgrowth modulators
|
|
US5986054A
(en)
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
US6221645B1
(en)
|
1995-06-07 |
2001-04-24 |
Elan Pharmaceuticals, Inc. |
β-secretase antibody
|
|
DE69635207T2
(de)
|
1995-07-07 |
2006-06-22 |
Darwin Molecular Corp. |
Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
|
|
US6156311A
(en)
|
1995-07-27 |
2000-12-05 |
The American National Red Cross |
Modulators of expression and function of LRP in alzheimer's disease
|
|
US5695937A
(en)
|
1995-09-12 |
1997-12-09 |
The Johns Hopkins University School Of Medicine |
Method for serial analysis of gene expression
|
|
FR2741892B1
(fr)
|
1995-12-04 |
1998-02-13 |
Pasteur Merieux Serums Vacc |
Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus
|
|
US5936078A
(en)
|
1995-12-12 |
1999-08-10 |
Kyowa Hakko Kogyo Co., Ltd. |
DNA and protein for the diagnosis and treatment of Alzheimer's disease
|
|
AUPN896596A0
(en)
|
1996-03-27 |
1996-04-26 |
Walter And Eliza Hall Institute Of Medical Research, The |
Therapeutic molecules
|
|
DE69736976T2
(de)
|
1996-03-29 |
2007-10-18 |
Trustees Of Boston University, Boston |
Mit Alzheimer Krankheit verknüpften Verfahren zur Diagnose, zur Herstellung von Medikamenten und zum Screenen von Substanzen sowie aus Beta-Amyloid abgeleiteten Peptiden
|
|
US6455277B1
(en)
|
1996-04-22 |
2002-09-24 |
Amgen Inc. |
Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
|
|
US5663059A
(en)
|
1996-05-10 |
1997-09-02 |
Incyte Pharmaceuticals, Inc. |
Human phospholipase inhibitor
|
|
US6010878A
(en)
|
1996-05-20 |
2000-01-04 |
Smithkline Beecham Corporation |
Interleukin-1 β converting enzyme like apoptotic protease-6
|
|
CA2183901A1
(en)
|
1996-08-22 |
1998-02-23 |
Johanna E. Bergmann |
Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
|
|
EP2172478A3
(en)
|
1997-02-07 |
2010-07-28 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Activity-dependent neurotrophic factor III (ADNF III)
|
|
US6413940B1
(en)
|
1997-02-07 |
2002-07-02 |
Nymox Corporation |
Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS
|
|
US6087153A
(en)
|
1997-07-24 |
2000-07-11 |
The Trustees Of Columbia University In The City Of New York |
Sel-10 and uses thereof
|
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
|
US7384910B2
(en)
|
1997-10-08 |
2008-06-10 |
Castillo Gerardo M |
Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
|
|
US6242421B1
(en)
|
1997-11-06 |
2001-06-05 |
Richard Lloyd Bowen |
Methods for preventing and treating Alzheimer's disease
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US7189703B2
(en)
|
1998-01-09 |
2007-03-13 |
Intracell, Llc |
Treatment and diagnosis of alzheimer's disease
|
|
GB9816575D0
(en)
|
1998-07-31 |
1998-09-30 |
Zeneca Ltd |
Novel compounds
|
|
US20050032675A1
(en)
|
1998-08-06 |
2005-02-10 |
Teijin Limited |
Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
|
|
AU5065399A
(en)
|
1998-08-06 |
2000-02-28 |
Teijin Limited |
Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
|
|
ES2260570T3
(es)
|
1998-08-27 |
2006-11-01 |
Spirogen Limited |
Pirrolobenziodiazepinas dimericas.
|
|
GB9818730D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Collections of compounds
|
|
GB9818731D0
(en)
|
1998-08-27 |
1998-10-21 |
Univ Portsmouth |
Compounds
|
|
ID29573A
(id)
|
1998-09-17 |
2001-09-06 |
Otsuka Pharma Co Ltd |
Gen ly6h
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
WO2000032805A1
(en)
|
1998-12-02 |
2000-06-08 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
|
|
US6982089B2
(en)
|
1999-02-24 |
2006-01-03 |
Tact Ip, Llc |
Cytokine antagonists for neurological and neuropsychiatric disorders
|
|
DE19909357A1
(de)
|
1999-03-03 |
2000-09-07 |
Gerd Multhaup |
Kupferagonist, der an die Kupferbindungsstelle von APP bindet und/oder eine hemmende Wirkung auf die Freisetzung des Amyloid-Aß-Peptids ausübt
|
|
DE19910108C2
(de)
|
1999-03-08 |
2001-02-22 |
Falk Fahrenholz |
Zellen, die ein Amyloidvorläuferprotein und eine alpha-Sekretase coexprimieren, ein Testverfahren zur Identifikation alpha-Sekretase-aktiver Substanzen sowie eines zur Identifikation weiterer Sekretasen, ein Testverfahren zur Bestimmung der Anfälligkeit gegenüber Morbus Alzheimer und Verwendung von Nukleinsäuren, die für eine alpha-Sekretase codieren, für die Gentherapie
|
|
AU4055000A
(en)
|
1999-04-13 |
2000-11-14 |
Daniel K. Hsu |
Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma
|
|
US6303576B1
(en)
|
1999-04-21 |
2001-10-16 |
Adherex Technologies Inc. |
Compounds and methods for modulating β-catenin mediated gene expression
|
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
EP1203816A4
(en)
|
1999-07-08 |
2004-12-08 |
Fujisawa Pharmaceutical Co |
AMYLOID BETA PROTEIN AGGLUTINATION CONTROLLING FACTOR
|
|
ATE225405T1
(de)
|
1999-07-09 |
2002-10-15 |
Pasteur Institut |
Verfahren zur diagnose oder zur prognose von alzheimer krankheit: therapeutische zusammensetzung zur verhinderung oder zur behandlung von alzheimer krankheit
|
|
AU783964B2
(en)
|
1999-08-06 |
2006-01-05 |
S.I.S.S.A. Scuola Internazionale Superiore Di Studi Avanzati |
Non-human transgenic animals for the study of neurodegenerative syndromes
|
|
JP2003509020A
(ja)
|
1999-09-03 |
2003-03-11 |
ラモット・ユニバーシティ・オーソリティ・フォー・アプライド・リサーチ・アンド・インダストリアル・ディベロップメント・リミテッド |
プラーク形成疾患の診断、治療、予防に有用な薬剤、組成物、その使用法
|
|
US6255054B1
(en)
|
1999-09-09 |
2001-07-03 |
Jacques Hugon |
Polymorphism of the human GluR-5 gene and risk factor for alzheimer disease
|
|
US7314864B1
(en)
|
1999-09-17 |
2008-01-01 |
Keio University |
Humanin, a polypeptide suppressing neuronal death
|
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
|
CN1241940C
(zh)
|
2000-02-14 |
2006-02-15 |
株式会社Bf研究所 |
新型胶原蛋白样蛋白clac、其前体和它们的编码基因
|
|
EA006606B1
(ru)
|
2000-02-24 |
2006-02-24 |
Вашингтон Юниверсити |
Гуманизированное антитело и его фрагмент, взаимодействующие с бета-амилоидным пептидом, и способы их применения
|
|
US20060148712A1
(en)
|
2000-03-13 |
2006-07-06 |
Fu-Tong Liu |
Monocyte chemoattractant activity of galectin-3
|
|
US7186681B2
(en)
|
2000-03-13 |
2007-03-06 |
La Jolla Institute For Allergy And Immunology |
Methods of modulating cell migration using galectin-3
|
|
CN1450908A
(zh)
|
2000-06-28 |
2003-10-22 |
普拉纳生物技术有限公司 |
神经毒性寡聚体
|
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
|
AU2001268005A1
(en)
|
2000-07-07 |
2002-01-21 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
US6825164B1
(en)
|
2000-08-14 |
2004-11-30 |
The Trustees Of Columbia University In The City Of New York |
Method to increase cerebral blood flow in amyloid angiopathy
|
|
EP1233259A4
(en)
|
2000-09-21 |
2005-06-22 |
Matsushita Electric Industrial Co Ltd |
SENSOR MICROSCOPE-PROBE PROBE, PROCESS FOR PRODUCING SAME, SCANNING MICROSCOPE PROBE HAVING SAME, AND POLYMER PROCESSING METHOD USING SAME MICROSCOPE
|
|
US7471798B2
(en)
*
|
2000-09-29 |
2008-12-30 |
Knowles Electronics, Llc |
Microphone array having a second order directional pattern
|
|
KR100395254B1
(ko)
|
2000-10-30 |
2003-08-21 |
(주)자리타 바이오텍 |
종양 발생 예측 키트
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7264810B2
(en)
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
|
ES2305234T3
(es)
|
2001-02-27 |
2008-11-01 |
Blanchette Rockefeller Neurosciences Institute |
Diagnostico de la enfermedad de alzheimer basado en la fosforilacion de una proteina quinosa activada por mitogeno.
|
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
|
DE60227650D1
(de)
|
2001-04-14 |
2008-08-28 |
Evotec Neurosciences Gmbh |
Verwendung eines zum kern beschränkten protein für die diagnose und therapie von alzheimer-krankheit und relatierte neurodegeneratiefe störungen
|
|
AU2002258808A1
(en)
|
2001-04-30 |
2002-11-11 |
Eli Lilly And Company |
Humanized antibodies
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6906169B2
(en)
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
DE10130166A1
(de)
|
2001-06-22 |
2003-01-16 |
Elegene Ag I Ins |
Identifizierung von ses-1 sowie dessen Verwendungen
|
|
DE10130247A1
(de)
|
2001-06-22 |
2003-01-16 |
Elegene Ag I Ins |
Identifizierung von ses-3 sowie dessen Verwendungen
|
|
US6831699B2
(en)
|
2001-07-11 |
2004-12-14 |
Chang Industry, Inc. |
Deployable monitoring device having self-righting housing and associated method
|
|
EP1420032B2
(en)
|
2001-08-03 |
2015-12-16 |
Medical & Biological Laboratories Co., Ltd. |
Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody
|
|
WO2003023405A1
(en)
|
2001-09-07 |
2003-03-20 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
AU2003208857A1
(en)
|
2002-02-14 |
2003-09-04 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of caps
|
|
CA2478636A1
(en)
|
2002-03-04 |
2003-09-12 |
Nymox Corporation |
Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
|
|
IL163812A0
(en)
|
2002-03-05 |
2005-12-18 |
Univ Ramot |
Immunizing composition and method for inducing an immune response against the -secretase cleavage site of amyloid precursor protein
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP1485410B1
(en)
|
2002-03-21 |
2007-06-20 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases
|
|
KR100994748B1
(ko)
|
2002-04-19 |
2010-11-17 |
더 가버닝 카운실 오브 더 유니버시티 오브 토론토 |
알쯔하이머병의 치료를 위한 면역학적 방법 및 조성물
|
|
WO2003091734A1
(en)
|
2002-04-24 |
2003-11-06 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases
|
|
US20050032673A1
(en)
|
2002-06-10 |
2005-02-10 |
John Constance M. |
Sustained release N-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating disease
|
|
AU2003245589A1
(en)
|
2002-06-21 |
2004-01-06 |
Reuven Avrohom Cyrulnik |
System and method for noninvasive diagnostic imaging
|
|
WO2004003563A2
(en)
|
2002-06-27 |
2004-01-08 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases
|
|
US7141137B2
(en)
|
2002-07-10 |
2006-11-28 |
University Of Maine System Board Of Trustees |
Method of making laminated wood beams with varying lamination thickness throughout the thickness of the beam
|
|
WO2004007722A2
(en)
|
2002-07-12 |
2004-01-22 |
Axon Neuroscience Forschungs- Und Entwicklungs Gmbh |
Transgenic animal expressing alzheimer’s tau protein
|
|
BR0312792A
(pt)
|
2002-07-19 |
2005-05-03 |
Cytos Biotechnology Ag |
Composições de vacinas contendo séries antigênicas de amilóide beta1-6
|
|
ES2369542T3
(es)
|
2002-07-31 |
2011-12-01 |
Seattle Genetics, Inc. |
Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
AU2003279216A1
(en)
|
2002-10-09 |
2004-05-04 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
|
AT413945B
(de)
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
|
KR20050118669A
(ko)
|
2003-02-01 |
2005-12-19 |
뉴랄랩 리미티드 |
가용성 ａ-베타에 대한 항체를 생성하기 위한 능동 면역화
|
|
WO2004070388A1
(en)
|
2003-02-04 |
2004-08-19 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of scn2b protein for neurodegenerative diseases
|
|
ES2344645T3
(es)
|
2003-02-10 |
2010-09-02 |
Applied Molecular Evolution, Inc. |
Moleculas de union al abeta.
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
US20040223971A1
(en)
*
|
2003-04-07 |
2004-11-11 |
Glycogenesys, Inc. |
Composition and uses of galectin antagonists
|
|
EP1980257A1
(en)
|
2003-04-07 |
2008-10-15 |
Prospect Therapeutics, Inc. |
Compositions and uses of galectin antagonists
|
|
US7732162B2
(en)
|
2003-05-05 |
2010-06-08 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
|
|
ES2246177B1
(es)
|
2003-05-08 |
2007-03-01 |
Universidad De Zaragoza. |
Uso de anticuerpos para el tratamiento de enfermedades amiloideas.
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
WO2004111654A2
(en)
|
2003-06-06 |
2004-12-23 |
Ciphergen Biosystems, Inc. |
Serum biomarkers in ischaemic heart disease
|
|
JP4888876B2
(ja)
|
2003-06-13 |
2012-02-29 |
田平 武 |
アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
|
|
US7384523B2
(en)
|
2003-07-10 |
2008-06-10 |
Radiometer Medical Aps |
Chloride ion selective membrane and sensor
|
|
KR20060054365A
(ko)
|
2003-07-28 |
2006-05-22 |
에스아이지 테크놀로지 리미티드 |
포일 물질로 밀봉된 콤비팩이나 용기를 위한 관통 엣지설비가 구비된 주입 마개
|
|
CA2534950A1
(en)
|
2003-08-08 |
2005-02-24 |
Schering Corporation |
Cyclic amine bace-1 inhibitors having a benzamide substituent
|
|
CN1863770B
(zh)
|
2003-08-08 |
2011-05-25 |
先灵公司 |
具有杂环取代基的环胺base-1抑制剂
|
|
US7625711B2
(en)
|
2003-09-05 |
2009-12-01 |
Hisamitsu Pharmaceutical Co., Inc. |
Screening method for the identification of a drug for the development of an agent for prevention and/or treatment of Alzheimer's disease
|
|
AT413336B
(de)
|
2003-09-12 |
2006-02-15 |
Mattner Frank Dr |
Apherese-vorrichtung
|
|
US20060223065A1
(en)
|
2003-09-30 |
2006-10-05 |
Evotec Neuroscience Gmbh |
Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases
|
|
US7700823B2
(en)
|
2003-10-02 |
2010-04-20 |
Aventis Pharma S.A. |
Transgenic animals exhibiting major disorders related to Alzheimer's disease
|
|
JP2008500013A
(ja)
*
|
2003-10-03 |
2008-01-10 |
ザ ブライハム アンド ウイメンズ ホスピタル，インコーポレイテッド |
Ｔｉｍ−３ポリペプチド
|
|
GB0416511D0
(en)
|
2003-10-22 |
2004-08-25 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
WO2005071418A2
(en)
|
2003-10-29 |
2005-08-04 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of the human dax- 1 gene and protein for neurodegenerative diseases
|
|
HUE038955T2
(hu)
|
2003-11-05 |
2018-12-28 |
Roche Glycart Ag |
Antigén-kötõ molekulák fokozott Fc receptor-kötõ affinitással és effektor funkcióval
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
WO2005058352A2
(en)
|
2003-12-17 |
2005-06-30 |
Entelos, Inc. |
Treatment of rheumatoid arthritis with galectin-3 antagonists
|
|
HRP20070241T3
(hr)
|
2003-12-19 |
2007-07-31 |
Bristol-Myers Squibb Company |
Azabiciklički heterocikli kao modulatori kanabinoid receptora
|
|
US7807157B2
(en)
|
2004-02-20 |
2010-10-05 |
Intellect Neurosciences Inc. |
Monoclonal antibodies and use thereof
|
|
US8060179B1
(en)
|
2006-11-16 |
2011-11-15 |
Scientific Nanomedicine, Inc. |
Biomagnetic detection and treatment of Alzheimer's Disease
|
|
WO2005085472A2
(en)
|
2004-03-03 |
2005-09-15 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases
|
|
EP1723152B1
(en)
|
2004-03-09 |
2015-02-11 |
Spirogen Sàrl |
Pyrrolobenzodiazepines
|
|
CA2558034A1
(en)
|
2004-03-09 |
2005-09-22 |
Elan Pharmaceuticals, Inc. |
Substituted hydroxyethylamine aspartyl protease inhibitors
|
|
CA2564432A1
(en)
|
2004-04-27 |
2005-11-10 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Human anti-amyloid .beta. peptide antibody and fragment of said antibody
|
|
US7629443B2
(en)
|
2004-06-02 |
2009-12-08 |
New York Blood Center, Inc. |
Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
ES2415665T3
(es)
|
2004-06-21 |
2013-07-26 |
Proteome Sciences Plc |
Procedimientos de cribado usando c-abl, fyn y sky en combinación con la proteína tau
|
|
JP4651620B2
(ja)
|
2004-07-07 |
2011-03-16 |
三菱電機株式会社 |
電力算出装置、電力算出方法、耐タンパ性評価装置及び耐タンパ性評価方法
|
|
AT413946B
(de)
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
|
AT500483B1
(de)
|
2004-07-13 |
2006-01-15 |
Mattner Frank Dr |
Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
|
|
US7955812B2
(en)
|
2004-07-19 |
2011-06-07 |
The General Hospital Corporation |
Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
|
|
US20060024667A1
(en)
|
2004-07-29 |
2006-02-02 |
Karen Manucharyan |
Compositions and methods for Alzheimer's disease
|
|
CA2575340A1
(en)
|
2004-07-28 |
2006-02-09 |
Schering Corporation |
Macrocyclic beta-secretase inhibitors
|
|
ES2473587T3
(es)
|
2004-08-03 |
2014-07-07 |
Transtech Pharma, Inc. |
Proteínas de fusión de RAGE y métodos de uso
|
|
WO2006015976A1
(en)
|
2004-08-11 |
2006-02-16 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of a plasma membrane atpase
|
|
CA2576405A1
(en)
|
2004-08-11 |
2006-02-16 |
Mitsubishi Chemical Corporation |
Antibody and utilization of the same
|
|
GB0421639D0
(en)
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
|
ATE459650T1
(de)
|
2004-10-08 |
2010-03-15 |
Univ Liege |
KOMPLEMENTÄRE PEPTIDE FÜR ß-AMYLOID 29-42-PEPTID
|
|
US9907485B2
(en)
|
2004-10-15 |
2018-03-06 |
Brainlab Ag |
Targeted immunization and plaque destruction against Alzheimer's disease
|
|
KR20070094890A
(ko)
|
2004-10-25 |
2007-09-27 |
머크 앤드 캄파니 인코포레이티드 |
안티 ａｄｄｌ 항체 및 그 용도
|
|
JP2008519863A
(ja)
|
2004-11-12 |
2008-06-12 |
シアトル ジェネティクス インコーポレイティッド |
Ｎ末端にアミノ安息香酸単位を有するオーリスタチン
|
|
ES2396555T3
(es)
|
2004-12-15 |
2013-02-22 |
Janssen Alzheimer Immunotherapy |
Anticuerpos que reconocen péptido beta amiloide
|
|
US8257740B1
(en)
|
2011-08-15 |
2012-09-04 |
Gp Medical, Inc. |
Pharmaceutical composition of nanoparticles
|
|
US20060257359A1
(en)
|
2005-02-28 |
2006-11-16 |
Cedric Francois |
Modifying macrophage phenotype for treatment of disease
|
|
US7632634B2
(en)
|
2005-04-15 |
2009-12-15 |
University Of Maryland Biotechnology Institute |
Method and assay for early diagnosis of prostate cancer
|
|
WO2006112553A2
(en)
|
2005-04-20 |
2006-10-26 |
Dnavec Corporation |
Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
|
|
ES2338696T3
(es)
|
2005-04-21 |
2010-05-11 |
Spirogen Limited |
Pirrolobenzodiazepinas.
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
WO2006121656A2
(en)
|
2005-05-05 |
2006-11-16 |
Merck & Co., Inc. |
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
|
|
EP3530736A3
(en)
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
|
US8114620B2
(en)
|
2005-05-30 |
2012-02-14 |
Takeda Pharmaceutical Company Limited |
Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases
|
|
WO2006128902A1
(en)
|
2005-06-01 |
2006-12-07 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic target slc39a12 proteins for neurodegenerative diseases
|
|
ATE489370T1
(de)
|
2005-06-14 |
2010-12-15 |
Schering Corp |
Herstellung und verwendung von verbindungen als aspartylproteasehemmer
|
|
US8722708B2
(en)
|
2005-06-14 |
2014-05-13 |
Merck Sharp & Dohme Inc. |
Substituted isoindolines as aspartyl protease inhibitors
|
|
EP1891241B1
(en)
|
2005-06-16 |
2011-01-12 |
EVOTEC Neurosciences GmbH |
Diagnostic and therapeutic target adarb2 proteins for neurodegenerative diseases
|
|
ATE439443T1
(de)
|
2005-06-17 |
2009-08-15 |
Ca Nat Research Council |
NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON
|
|
DE102005029729A1
(de)
|
2005-06-24 |
2006-12-28 |
Röchling Automotive AG & Co. KG |
Verkleidungs- oder Gehäuseteil eines Fahrzeugs und Verfahren zu seiner Herstellung
|
|
WO2007008848A2
(en)
|
2005-07-07 |
2007-01-18 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus
|
|
US20070021282A1
(en)
|
2005-07-19 |
2007-01-25 |
Karp Shaun A |
Abdominal exercising and strength testing systems
|
|
CA2619725C
(en)
|
2005-08-18 |
2016-06-07 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
EP1957093B1
(en)
|
2005-08-29 |
2017-04-12 |
SHASHOUA, Victor E. |
Neuroprotective and neurorestorative methods and compositions
|
|
WO2007062088A1
(en)
|
2005-11-22 |
2007-05-31 |
The Trustees Of The University Of Pennsylvania |
Antibody treatment of alzheimer's and related diseases
|
|
JP2009518010A
(ja)
|
2005-11-30 |
2009-05-07 |
アボット・ラボラトリーズ |
ヒトβアミロイドタンパク質の組み換え形態の調製方法及びこれらのタンパク質の使用
|
|
PL1976877T5
(pl)
|
2005-11-30 |
2017-09-29 |
Abbvie Inc |
Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
|
|
DK1813614T3
(da)
|
2006-01-25 |
2012-01-23 |
Sanofi Sa |
Cytotoksiske midler, der omfatter nye tomaymycinderivater
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
CN101421299A
(zh)
|
2006-02-22 |
2009-04-29 |
株式会社林原生物化学研究所 |
用于诱导产生抗淀粉样β肽抗体的肽疫苗
|
|
EP2514824A3
(en)
|
2006-03-03 |
2013-01-23 |
Amorfix Life Sciences Ltd. |
Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
|
|
MY169492A
(en)
|
2006-03-23 |
2019-04-15 |
Bioarctic Neuroscience Ab |
Improved protofibril selective antibodies and the use thereof
|
|
EP2005187A4
(en)
|
2006-03-23 |
2010-04-21 |
Life Technologies Corp |
METHOD AND REAGENTS FOR IN VIVO IMAGING CANCER CELL LINES
|
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
EP2011513B1
(en)
|
2006-04-25 |
2016-10-19 |
The University of Tokyo |
Therapeutic agents for alzheimer's disease and cancer
|
|
US8357781B2
(en)
|
2006-06-01 |
2013-01-22 |
Janssen Alzheimer Immunotherapy |
Neuroactive fragments of APP
|
|
WO2008004346A1
(fr)
|
2006-07-06 |
2008-01-10 |
Nec Corporation |
Procédé et dispositif de conception d'une hiérarchie de circuit intégré semi-conducteur
|
|
AU2007285763B2
(en)
|
2006-08-18 |
2011-12-15 |
Armagen Technologies, Inc. |
Agents for blood-brain barrier delivery
|
|
WO2008029886A1
(en)
|
2006-09-06 |
2008-03-13 |
National University Corporation Tottori University |
Kit for diagnosis of alzheimer's disease, diagnostic marker, and method for detection of indicator for disease condition
|
|
US20100330602A1
(en)
|
2006-09-19 |
2010-12-30 |
Emory University |
Use of Soluble Galectin-3 (Gal-3) for Cancer Treatment
|
|
WO2008085564A2
(en)
|
2006-09-20 |
2008-07-17 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods involving truncated recombinant seven g-protein coupled receptors
|
|
US8420613B2
(en)
|
2006-11-15 |
2013-04-16 |
The J. David Gladstone Institutes |
Methods and compositions for reducing amyloid beta levels
|
|
AU2007319806A1
(en)
|
2006-11-15 |
2008-05-22 |
The Brigham And Women's Hospital, Inc. |
Therapeutic uses of TIM-3 modulators
|
|
GB0624500D0
(en)
|
2006-12-07 |
2007-01-17 |
Istituto Superiore Di Sanito |
A novel passive vaccine for candida infections
|
|
WO2008073817A2
(en)
|
2006-12-08 |
2008-06-19 |
Dana-Farber Cancer Institute, Inc. |
Muc1 and galectin-3
|
|
PL3225251T3
(pl)
|
2006-12-21 |
2020-06-29 |
H. Lundbeck A/S |
Modulacja aktywności proneurotrofin
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
GEP20125693B
(en)
|
2007-01-09 |
2012-11-26 |
Biogen Idec Inc |
Sp35 antibodies and usage thereof
|
|
ES2610474T3
(es)
|
2007-01-11 |
2017-04-27 |
Michael Bacher |
Diagnóstico y tratamiento de la enfermedad de Alzheimer y otras enfermedades neurodegenerativas causantes de demencia
|
|
WO2008088983A1
(en)
|
2007-01-18 |
2008-07-24 |
Eli Lilly And Company |
PEGYLATED Aβ FAB
|
|
WO2008112559A1
(en)
|
2007-03-09 |
2008-09-18 |
Regents Of The University Of California |
Suppression of galectin-3 for treating an inflammatory condition
|
|
US8106015B2
(en)
|
2007-04-20 |
2012-01-31 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Method for enhancing immune response with peptide
|
|
EP2152744A4
(en)
|
2007-04-26 |
2012-02-15 |
Univ Yale |
PRION PROTEIN AS RECEPTOR FOR AMYLOID-BETA OLIGOMERS
|
|
WO2008133772A1
(en)
|
2007-04-26 |
2008-11-06 |
Ludwig Institute For Cancer Research |
Method for modulating activity of t lymphocytes
|
|
US9040045B2
(en)
|
2007-05-14 |
2015-05-26 |
Medtronic, Inc. |
Methods and device to neutralize soluble toxic agents in the brain
|
|
EP2435416B1
(en)
|
2007-07-05 |
2016-03-30 |
Merck Sharp & Dohme Corp. |
Tetrahydropyranochromene gamma secretase inhibitors
|
|
US8618123B2
(en)
|
2007-07-17 |
2013-12-31 |
Merck Sharp & Dohme Corp. |
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
|
|
PT2019104E
(pt)
|
2007-07-19 |
2013-12-03 |
Sanofi Sa |
Agentes citotóxicos compreendendo novos derivados de tomaimicina e sua utilização terapêutica
|
|
ES2498040T3
(es)
|
2007-07-27 |
2014-09-24 |
Janssen Alzheimer Immunotherapy |
Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
|
|
US8993833B2
(en)
|
2007-08-14 |
2015-03-31 |
Duke University |
Model of Alzheimer's Disease
|
|
JP2010536907A
(ja)
|
2007-08-31 |
2010-12-02 |
ニューリミューン セラピューティクス エイジー |
患者にアミロイドーシスおよびタンパク質凝集性障害における特異的免疫応答をもたらす方法
|
|
CN101848897A
(zh)
|
2007-09-06 |
2010-09-29 |
先灵公司 |
γ分泌酶调节剂
|
|
EP2527369A3
(en)
|
2007-09-13 |
2012-12-19 |
University Of Zurich Prorektorat Forschung |
Monoclonal amyloid beta (abeta)-specific antibody and uses thereof
|
|
CN101883792B
(zh)
|
2007-10-29 |
2014-08-27 |
基因创新有限公司 |
特异于β-淀粉状蛋白肽的新抗体以及其用作诊断剂或药物的用途
|
|
CN104098695B
(zh)
|
2007-10-29 |
2018-09-07 |
道健康生活医药株式会社 |
抗体及其应用
|
|
ES2445446T3
(es)
|
2007-11-01 |
2014-03-03 |
F. Hoffmann-La Roche Ag |
Animales no humanos cuatro veces transgénicos
|
|
US8487099B2
(en)
|
2007-11-05 |
2013-07-16 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
KR101397554B1
(ko)
|
2007-11-09 |
2014-05-21 |
재단법인서울대학교산학협력재단 |
치매(알츠하이머 병)의 진단, 예방, 치료제 및 이들의스크리닝 방법
|
|
MX2010005282A
(es)
|
2007-11-13 |
2010-08-31 |
Teva Pharma |
Anticuerpos humanizados contra tl1a.
|
|
AU2008322523B2
(en)
|
2007-11-16 |
2013-10-10 |
The Rockefeller University |
Antibodies specific for the protofibril form of beta-amyloid protein
|
|
US8349579B2
(en)
|
2007-12-13 |
2013-01-08 |
Wayne State University |
Galectin-3 cleavage as a marker for matrix metalloproteinase activity in cancer
|
|
WO2009087689A2
(en)
|
2008-01-07 |
2009-07-16 |
Council Of Scientific & Industrial Research |
Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis
|
|
ITNA20080006A1
(it)
|
2008-01-28 |
2009-07-29 |
Consiglio Nazionale Ricerche |
Proteine chimeriche capaci di formare particelle virus-like, che contengono sequenze peptidiche del beta-amiloide e la componente e2 della alfachetoacido deidrogenasi di "geobacillus stearothermophilus", utili per l'induzione di una risposta anticorp
|
|
PL2246427T3
(pl)
|
2008-02-08 |
2017-06-30 |
Immunas Pharma, Inc. |
Przeciwciała zdolne do wiązania się swoiście do oligomerów amyloidu beta i ich stosowanie
|
|
US8852874B2
(en)
|
2008-02-29 |
2014-10-07 |
Baxter International Inc. |
Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
|
|
FR2929292A1
(fr)
|
2008-03-28 |
2009-10-02 |
Exonhit Therapeutics S A Sa |
Procede et methodes de diagnostic de la maladie d'alzheimer
|
|
US9908943B2
(en)
|
2008-04-03 |
2018-03-06 |
Vib Vzw |
Single domain antibodies capable of modulating BACE activity
|
|
CN102065881B
(zh)
|
2008-04-14 |
2014-03-12 |
埃尔奇诺瓦公司 |
稳定的淀粉样beta单体和寡聚体
|
|
CN102089430B
(zh)
|
2008-05-09 |
2015-02-04 |
Abbvie公司 |
针对渐进性糖化终极产物受体(rage)的抗体及其用途
|
|
WO2009146301A1
(en)
|
2008-05-27 |
2009-12-03 |
Yale University |
TARGETING TGF-β AS A THERAPY FOR ALZHEIMER'S DISEASE
|
|
US8969023B2
(en)
|
2008-06-10 |
2015-03-03 |
Eleanore Bennett Charitable Trust #2 |
Methods and compositions for treating alzheimer's disease
|
|
EP2303001A4
(en)
|
2008-06-20 |
2016-07-13 |
Janssen Biotech Inc |
METHOD FOR VERIFYING THE EFFECTIVENESS OF TREATMENT OF NEUROLOGICAL ILLNESSES
|
|
WO2009155609A1
(en)
|
2008-06-20 |
2009-12-23 |
Oklahoma Medical Research Foundation |
IMMUNOGENIC MEMAPSIN 2 β-SECRETASE PEPTIDES AND METHODS OF USE
|
|
RU2653753C1
(ru)
|
2008-06-25 |
2018-05-14 |
ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи |
СТАБИЛЬНЫЕ И РАСТВОРИМЫЕ АНТИТЕЛА, ИНГИБИРУЮЩИЕ TNFα
|
|
US9045555B2
(en)
|
2008-07-01 |
2015-06-02 |
De Staat Der Nederlanden, Vert. Door De Minister Van Vws |
Vaccine against amyloid folding intermediate
|
|
CA2730048A1
(en)
|
2008-07-08 |
2010-01-14 |
Merck Sharp & Dohme Corp. |
Vaccine for the treatment of alzheimer's disease
|
|
CA3012229C
(en)
|
2008-07-08 |
2020-11-10 |
Incyte Holdings Corporation |
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
|
|
GB0813432D0
(en)
|
2008-07-22 |
2008-08-27 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
KR20160127181A
(ko)
|
2008-08-12 |
2016-11-02 |
진판델 파마슈티컬스 인코포레이티드 |
질환 위험 인자의 식별 방법
|
|
US8283322B2
(en)
|
2008-08-15 |
2012-10-09 |
Orthopeutics, Lp |
Formulations for nonsurgical exogenous crosslink therapy
|
|
EP2679238A1
(en)
|
2008-10-02 |
2014-01-01 |
Celtaxsys, INC. |
Methods of modulating the negative chemotaxis of immune cells
|
|
BRPI0919975A2
(pt)
*
|
2008-10-29 |
2015-12-15 |
Bg Medicine Inc |
imunoensaio para galectina-3
|
|
JP2012507300A
(ja)
|
2008-10-30 |
2012-03-29 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス |
Ｒｎａパターンを評価する方法
|
|
JP5503663B2
(ja)
|
2008-11-13 |
2014-05-28 |
メルク・シャープ・アンド・ドーム・コーポレーション |
ガンマセクレターゼモジュレータ
|
|
AU2009314205A1
(en)
|
2008-11-13 |
2010-05-20 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
DE102008037564A1
(de)
|
2008-11-19 |
2010-05-20 |
Forschungszentrum Jülich GmbH |
Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
|
|
US8912145B2
(en)
|
2008-11-28 |
2014-12-16 |
Hokko Chemical Industry Co., Ltd. |
Vaccine composition for prophylaxis and/or therapy of Alzheimer's disease
|
|
EP2373338B1
(en)
*
|
2008-12-03 |
2017-02-15 |
The Johns Hopkins University |
Annexina2 as immunological target
|
|
US20120046181A1
(en)
|
2008-12-19 |
2012-02-23 |
Chu Nantes |
Biomarkers for the Diagnosis of Renal Allograft and Kidney Status
|
|
AU2009330233A1
(en)
|
2008-12-22 |
2011-07-07 |
Merck Sharp & Dohme Corp. |
Gamma secretase modulators
|
|
US20100196882A1
(en)
|
2009-02-04 |
2010-08-05 |
Avraham Raz |
GALECTIN-3 nsSNP MARKER FOR CANCER
|
|
CA3014224C
(en)
|
2009-02-05 |
2022-05-24 |
Immunogen, Inc. |
Condensed benzodiazepine-indoline derivatives and processes to prepare said derivatives
|
|
FR2942476B1
(fr)
|
2009-02-20 |
2013-03-15 |
Commissariat Energie Atomique |
Composes de type pyridocarbazole et leurs applications
|
|
MX2011009654A
(es)
|
2009-03-18 |
2011-10-12 |
Ac Immune Sa |
Metodo para uso terapeutico.
|
|
US9173928B2
(en)
|
2009-03-26 |
2015-11-03 |
Yoh Matsumoto |
DNA vaccine for Alzheimer's disease
|
|
JP2010268789A
(ja)
|
2009-04-24 |
2010-12-02 |
Kumamoto Univ |
細胞医薬の製造方法
|
|
FR2945538B1
(fr)
|
2009-05-12 |
2014-12-26 |
Sanofi Aventis |
Anticorps humanises specifiques de la forme protofibrillaire du peptide beta-amyloide.
|
|
EP2258398A1
(en)
|
2009-05-26 |
2010-12-08 |
Araclón Biotech, S. L. |
Albumin-amyloid peptide conjugates and uses thereof
|
|
EP4218794A3
(en)
|
2009-06-10 |
2023-09-13 |
New York University |
Immunological targeting of pathological tau proteins
|
|
CA2764545C
(en)
|
2009-06-15 |
2019-05-14 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Bace1 inhibitory antibodies
|
|
WO2010147969A2
(en)
|
2009-06-16 |
2010-12-23 |
Schering Corporation |
Gamma secretase modulators
|
|
SI2448968T1
(sl)
|
2009-06-29 |
2021-07-30 |
Bioarctic Ab |
Protitelesa, selektivna za protofibrile/oligomere na N-koncu skrajšanega amiloida-beta
|
|
EP2273273A1
(en)
|
2009-07-11 |
2011-01-12 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Inhibitors of the nitration of amyloid ß peptides and their uses in the diagnosis and treatment of alzheimer's disease
|
|
JP5423882B2
(ja)
|
2009-07-15 |
2014-02-19 |
富士電機株式会社 |
超接合半導体装置
|
|
WO2011016238A1
(en)
|
2009-08-06 |
2011-02-10 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
MX2012001708A
(es)
|
2009-08-07 |
2012-05-22 |
Kyowa Hakko Kirin Co Ltd |
Anticuerpo humanizado anti-oligomero de amiloide b.
|
|
EA201270316A1
(ru)
|
2009-08-25 |
2012-09-28 |
БиДжи МЕДИСИН, ИНК. |
Галектин-3 и сердечная ресинхронизирующая терапия
|
|
EP2470211B1
(en)
|
2009-08-28 |
2016-01-27 |
The Board of Regents of The University of Texas System |
Antibodies that bind tau oligomers
|
|
WO2011031720A1
(en)
|
2009-09-11 |
2011-03-17 |
Arizona Board Of Regents Acting For And On Behalf Of Arizona State University |
Bispecific nanobodies as a therapeutic for alzheimer's disease
|
|
DE102009043750A1
(de)
|
2009-09-30 |
2011-08-04 |
Carl Zeiss Meditec AG, 07745 |
Verfahren und Vorrichtung zur Detektion von Ablagerungen im Auge
|
|
JPWO2011045945A1
(ja)
|
2009-10-16 |
2013-03-04 |
国立大学法人京都大学 |
アミロイドβのターン構造を認識する抗体
|
|
WO2011102901A1
(en)
|
2010-02-20 |
2011-08-25 |
Ebiotec (Euroespes Biotechnology) |
Prevention and treatment of alzheimer's disease by amyloid beta peptide and sphingosine-1-phosphate
|
|
EP2542571B1
(en)
|
2010-03-03 |
2016-05-25 |
The University of British Columbia |
Oligomer-specific amyloid beta epitope and antibodies
|
|
EP2550361B1
(en)
|
2010-03-25 |
2017-02-08 |
The J. David Gladstone Institutes |
Compositions and methods for treating neurological disorders
|
|
EA201291040A1
(ru)
|
2010-04-13 |
2013-04-30 |
Бакстер Интернэшнл Инк. |
Использование скорости увеличения желудочков при лечении болезни альцгеймера внутривенным иммуноглобулином
|
|
CN103068405A
(zh)
|
2010-04-15 |
2013-04-24 |
西雅图基因公司 |
靶向吡咯并苯并二氮杂卓结合物
|
|
MX368648B
(es)
|
2010-04-15 |
2019-10-09 |
Seattle Genetics Inc |
Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
|
|
WO2011148668A1
(ja)
|
2010-05-25 |
2011-12-01 |
株式会社 島津製作所 |
大腸がんマーカーガレクチン、採血試料中のガレクチン濃度の分析方法及び大腸がんマーカーガレクチン検出キット
|
|
JP2013531981A
(ja)
|
2010-06-11 |
2013-08-15 |
アンチセンス・ファーマ・ゲーエムベーハー |
選択的オリゴヌクレオチド修飾の方法
|
|
US20130115227A1
(en)
|
2010-07-14 |
2013-05-09 |
Renee C. Gaspar |
Anti-addl monoclonal antibody and uses thereof
|
|
US10420923B1
(en)
|
2010-08-10 |
2019-09-24 |
Amiram Katz |
Method and device for intrathecal administering of immunoglobulin
|
|
SI3339323T1
(sl)
|
2010-08-12 |
2019-12-31 |
Eli Lilly And Company |
Protitelesa proti N3PGLU amiloid beta peptidu in njihove uporabe
|
|
WO2012036786A1
(en)
|
2010-09-17 |
2012-03-22 |
University Of L'aquila |
Nanoparticles of cerium oxide targeted to an amyloid-beta antigen of alzheimer's disease
|
|
US9090629B2
(en)
|
2010-11-03 |
2015-07-28 |
Immunogen, Inc. |
Cytotoxic agents comprising new ansamitocin derivatives
|
|
WO2012066495A2
(en)
|
2010-11-17 |
2012-05-24 |
Ben Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
|
CN103443125B
(zh)
|
2010-11-30 |
2019-05-03 |
霍夫曼-拉罗奇有限公司 |
低亲和力血脑屏障受体抗体及其用途
|
|
CN103370620B
(zh)
|
2010-12-28 |
2016-01-20 |
大日本住友制药株式会社 |
阿尔茨海默病的诊断药和诊断方法
|
|
WO2012106363A2
(en)
|
2011-01-31 |
2012-08-09 |
Intellect Neurosciences Inc. |
Treatment of tauopathies
|
|
CN103718046B
(zh)
|
2011-03-17 |
2016-10-12 |
重症监护诊断股份有限公司 |
预测不良临床结果的风险的方法
|
|
EP2508212A1
(en)
|
2011-04-05 |
2012-10-10 |
Universitätsklinikum Freiburg |
Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
|
|
WO2012136552A1
(en)
|
2011-04-08 |
2012-10-11 |
H. Lundbeck A/S |
ANTIBODIES SPECIFIC TO PYROGLUTAMATED Αβ
|
|
KR101589135B1
(ko)
|
2011-04-20 |
2016-01-29 |
주식회사 셀앤바이오 |
인간화 항-ｅｍａｐｉｉ 항체 및 이의 용도
|
|
US20140086836A1
(en)
|
2011-05-03 |
2014-03-27 |
Mental Health Research Institute |
Method for detection of a neurological disease
|
|
GB201108490D0
(en)
|
2011-05-18 |
2011-07-06 |
Ucl Business Plc |
Methods and uses
|
|
CN103857689A
(zh)
|
2011-05-19 |
2014-06-11 |
哈佛大学的校长及成员们 |
Osw-1类似物和缀合物，及其用途
|
|
AR086543A1
(es)
*
|
2011-05-25 |
2014-01-08 |
Bg Medicine Inc |
Inhibidores de galectina-3 y metodos de uso de los mismos, composicion farmaceutica
|
|
WO2012177837A2
(en)
|
2011-06-21 |
2012-12-27 |
Immunogen, Inc. |
Novel maytansinoid derivatives with peptide linker and conjugates thereof
|
|
WO2013008402A1
(ja)
|
2011-07-08 |
2013-01-17 |
シャープ株式会社 |
薄膜トランジスタ基板及びそれを備えた表示装置
|
|
GB201113482D0
(en)
|
2011-08-04 |
2011-09-21 |
Univ Liverpool |
Assay
|
|
LT2748201T
(lt)
|
2011-08-23 |
2018-02-26 |
Roche Glycart Ag |
Dvigubai specifinė t ląsteles aktyvinantį antigeną surišanti molekulė
|
|
US9365647B2
(en)
|
2011-09-19 |
2016-06-14 |
University Of The Witwatersrand, Johannesburg |
Compounds for use in the treatment of Alzheimer's disease
|
|
EP3275461A1
(en)
|
2011-09-19 |
2018-01-31 |
Axon Neuroscience SE |
Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease field
|
|
EP2748337B1
(en)
|
2011-09-23 |
2019-08-07 |
Siemens Healthcare Diagnostics Inc. |
Cell response assay for cancer and methods of producing and using same
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
US8764695B2
(en)
|
2012-09-28 |
2014-07-01 |
Isaac Eliaz |
Reduction of galectin-3 levels by plasmapheresis
|
|
KR20140067173A
(ko)
|
2011-12-08 |
2014-06-03 |
이삭 엘리아스 |
혈장사혈에 의한 갈렉틴-3 레벨의 감소
|
|
US9549953B2
(en)
|
2011-12-08 |
2017-01-24 |
Eliaz Therapeutics, Inc. |
Galectin-3 plasmapheresis therapy
|
|
AU2012351963A1
(en)
|
2011-12-15 |
2014-06-26 |
The United States of America, as represented by Secretary, Department of Health & Human Services |
Identification of two novel biomarkers for Niemann-Pick disease type C
|
|
US20130164217A1
(en)
|
2011-12-21 |
2013-06-27 |
Meso Scale Technologies, Llc |
Method of diagnosing, preventing and/or treating dementia & related disorders
|
|
WO2013099806A1
(ja)
|
2011-12-29 |
2013-07-04 |
Ｔａｏヘルスライフファーマ株式会社 |
アミロスフェロイドが結合して成熟神経細胞死を誘発する標的分子、アミロスフェロイドが誘導する神経細胞死を抑制する方法及び物質、及びそれらの利用
|
|
CA2862999A1
(en)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
SG10201604810UA
(en)
|
2012-02-07 |
2016-08-30 |
Global Bio Therapeutics Inc |
Compartmentalized method of nucleic acid delivery and compositions and uses thereof
|
|
WO2013120497A1
(en)
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
|
US9475840B2
(en)
|
2012-02-27 |
2016-10-25 |
Universitat De Barcelona |
Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs
|
|
ITRM20120383A1
(it)
|
2012-03-20 |
2013-09-21 |
Uni Degli Studi Di Milano B Icocca |
Metodo e kit per la rivelazione di anticorpi.
|
|
KR20140145173A
(ko)
|
2012-03-26 |
2014-12-22 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
알츠하이머 질병 진단 및 알츠하이머 질병 진행 진단용 세포 마커
|
|
WO2013152313A1
(en)
|
2012-04-05 |
2013-10-10 |
The Regents Of The University Of California |
Compositions and methods for treating cancer and diseases and conditions responsive to growth factor inhibition
|
|
CA2869438C
(en)
|
2012-04-05 |
2021-08-17 |
Ac Immune S.A. |
Humanized tau antibody
|
|
WO2013169890A1
(en)
|
2012-05-08 |
2013-11-14 |
Bg Medicine, Inc. |
Systems and methods for assessing disease risk, status, and prognosis
|
|
DK3269736T3
(da)
|
2012-05-10 |
2020-01-13 |
Georg August Univ Goettingen Stiftung Oeffentlichen Rechts Univsmedizin |
Konformationsspecifikke antistoffer mod oligomerer af amyloid beta
|
|
CN104640572B
(zh)
|
2012-05-15 |
2018-04-27 |
索伦托医疗有限公司 |
药物偶联物，偶联方法，及其用途
|
|
US9682143B2
(en)
|
2012-08-14 |
2017-06-20 |
Ibc Pharmaceuticals, Inc. |
Combination therapy for inducing immune response to disease
|
|
FR2994803B1
(fr)
|
2012-08-30 |
2016-02-26 |
Oreal |
Modulation de la forme des fibres keratiniques
|
|
CA2883130A1
(en)
|
2012-08-31 |
2014-03-06 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of alzheimer's disease
|
|
EP3919079A1
(en)
|
2012-09-07 |
2021-12-08 |
Genentech, Inc. |
Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor
|
|
JP6415437B2
(ja)
*
|
2012-09-17 |
2018-10-31 |
ガレクティン・セラピューティクス・インコーポレイテッドＧａｌｅｃｔｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
癌の処置における特異的免疫療法を向上する方法
|
|
EP3456734B1
(en)
|
2012-10-04 |
2022-01-05 |
Research Development Foundation |
Serine protease molecules and therapies
|
|
KR102308915B1
(ko)
|
2012-10-15 |
2021-10-06 |
메디뮨 리미티드 |
아밀로이드 베타에 대한 항체
|
|
CA2892490A1
(en)
|
2012-11-26 |
2014-05-30 |
Caris Science, Inc. |
Biomarker compositions and methods
|
|
US9066928B1
(en)
|
2012-12-04 |
2015-06-30 |
University Of Kentucky Research Foundation |
Method, composition, and kit useful for treatment of alzheimer's disease
|
|
KR20210132742A
(ko)
|
2012-12-21 |
2021-11-04 |
알트루바이오 인코퍼레이티드 |
친수성 자기-희생 링커 및 그것의 포합체
|
|
US9433665B2
(en)
|
2013-01-11 |
2016-09-06 |
Cyvax, Inc. |
Vaccines for protection from and treatment of alzheimer's disease
|
|
WO2014123186A1
(ja)
|
2013-02-06 |
2014-08-14 |
公立大学法人横浜市立大学 |
抗セマフォリン３ａ抗体、並びにこれを用いたアルツハイマー病及び免疫・炎症性疾患の治療
|
|
WO2014131694A1
(en)
|
2013-02-26 |
2014-09-04 |
Roche Glycart Ag |
Bispecific t cell activating antigen binding molecules
|
|
WO2014134070A1
(en)
|
2013-02-26 |
2014-09-04 |
Baxter International Inc. |
Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
|
|
CN111363047A
(zh)
|
2013-03-12 |
2020-07-03 |
分子模板公司 |
用于引起细胞内化的cd20结合免疫毒素及其使用方法
|
|
MX363787B
(es)
|
2013-03-13 |
2019-04-03 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de los mismos.
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
AU2013203043B2
(en)
|
2013-03-15 |
2016-10-06 |
Takeda Pharmaceutical Company Limited |
Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
|
|
US9879076B2
(en)
|
2013-03-15 |
2018-01-30 |
Ramot At Tel Aviv University Ltd. |
Methods and compositions with immune therapy for treatment of dementia
|
|
ES2835716T3
(es)
|
2013-03-15 |
2021-06-23 |
Beth Israel Deaconess Medical Ct Inc |
Procedimientos y composiciones para la generación y el uso de anticuerpos específicos de conformación
|
|
EP2978446B1
(en)
|
2013-03-27 |
2020-03-04 |
The General Hospital Corporation |
Anti-cd33 antibody for use in treating alzheimer's disease
|
|
HUE044737T2
(hu)
|
2013-05-06 |
2019-11-28 |
Baxalta Inc |
Alzheimer-kór szubpopulációk kezelése egyesített immunglubulin G-vel
|
|
CA2911547A1
(en)
|
2013-05-31 |
2014-12-04 |
Regeneron Pharmaceuticals, Inc. |
Methods of using il-1 antagonists to treat alzheimer's disease
|
|
EP3013355B1
(en)
|
2013-06-25 |
2019-08-07 |
ICM - Institut du Cerveau et da la Moelle Epinière |
Il-2 for use in treating alzheimer disease and related disorders
|
|
WO2015031084A1
(en)
|
2013-08-28 |
2015-03-05 |
Jianfeng Cai |
Methods of synthesizing y-aapeptides, y-aapeptide building blocks, y-aapeptide libraries, and y-aapeptide inhibitors of ab40 aggregates
|
|
EP3043802B1
(en)
|
2013-09-13 |
2018-04-18 |
Merck Sharp & Dohme Corp. |
C5-spiro iminothiazine dioxides as bace inhibitors, compositions, and their use
|
|
WO2015038426A1
(en)
|
2013-09-13 |
2015-03-19 |
Asana Biosciences, Llc |
Self-immolative linkers containing mandelic acid derivatives, drug-ligand conjugates for targeted therapies and uses thereof
|
|
WO2015051850A1
(en)
|
2013-10-11 |
2015-04-16 |
Universität Für Bodenkultur Wien |
Compositions containing galectin-3 modulators for the treatment of bone disorders
|
|
AU2014337317A1
(en)
|
2013-10-15 |
2016-09-15 |
Sorrento Therapeutics Inc. |
Drug-conjugates with a targeting molecule and two different drugs
|
|
GB201319761D0
(en)
|
2013-11-08 |
2013-12-25 |
Nordic Bioscience As |
Biomarkers of disease progression
|
|
CR20160270A
(es)
|
2013-12-20 |
2016-09-05 |
Hoffmann La Roche |
ANTICUERPOS ANTI-TAU (pS422) HUMANIZADOS Y MÉTODOS DE UTILIZACIÓN
|
|
WO2015100353A1
(en)
|
2013-12-27 |
2015-07-02 |
Dignity Health |
Diagnosing and treating alzheimer's disease
|
|
US10272083B2
(en)
|
2014-01-21 |
2019-04-30 |
Acerta Pharma B.V. |
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
|
|
ES2749862T3
(es)
|
2014-01-27 |
2020-03-24 |
Molecular Templates Inc |
Polipéptidos efectores desinmunizados de subunidad A de toxina Shiga para aplicaciones en mamíferos
|
|
US20210138076A2
(en)
|
2014-01-27 |
2021-05-13 |
Molecular Templates, Inc. |
Cell-targeting molecules comprising shiga toxin a subunit effectors and cd8+ t-cell epitopes
|
|
US20160177284A1
(en)
|
2014-01-27 |
2016-06-23 |
Molecular Templates, Inc. |
Cell-targeted molecules comprising amino-terminus proximal or amino-terminal shiga toxin a subunit effector regions
|
|
PL3099717T3
(pl)
*
|
2014-01-31 |
2019-10-31 |
Novartis Ag |
Cząsteczki przeciwciała dla TIM-3 i ich zastosowanie
|
|
JP6814634B2
(ja)
|
2014-02-05 |
2021-01-20 |
モレキュラー テンプレーツ, インク.Molecular Templates, Inc. |
リボ毒性の一時的な減少に基づき、細胞毒性組換えポリペプチドをスクリーニングし、選択し、同定する方法
|
|
TW202239429A
(zh)
|
2014-02-08 |
2022-10-16 |
美商建南德克公司 |
治療阿茲海默症之方法
|
|
EP3125908A4
(en)
|
2014-03-10 |
2017-11-15 |
La Jolla Pharmaceutical Company |
Compositions and methods for treating kidney disorders
|
|
PT3604333T
(pt)
|
2014-03-11 |
2021-06-07 |
Molecular Templates Inc |
Proteínas compreendendo regiões efetoras da subunidade a da toxina shiga próximas de amino-terminais e regiões de ligação do tipo imunoglobulina de direcionamento celular capazes de se ligarem especificamente a cd38
|
|
ES2864124T3
(es)
|
2014-03-11 |
2021-10-13 |
Molecular Templates Inc |
Proteínas que comprenden regiones de unión, regiones efectoras de la subunidad A de toxina Shiga y motivos señal de localización de retículo endoplasmático carboxi terminal
|
|
KR20200029627A
(ko)
|
2014-03-12 |
2020-03-18 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
Cns의 질환 및 손상을 치료하기 위한 전신적 조절 t 세포 수준 또는 활성의 감소
|
|
JP6111002B1
(ja)
|
2014-04-10 |
2017-04-05 |
ファイザー・インク |
２−アミノ−６−メチル−４，４ａ，５，６−テトラヒドロピラノ［３，４−ｄ］［１，３］チアジン−８ａ（８Ｈ）−イル−１，３−チアゾール−４−イルアミド
|
|
WO2015159963A1
(ja)
|
2014-04-16 |
2015-10-22 |
協和発酵キリン株式会社 |
ヒトｃｓｆの毒性を測定する方法
|
|
US9737505B2
(en)
|
2014-04-29 |
2017-08-22 |
Glaxosmithkline Intellectual Property Development Limited |
Prodrug of 1,1′-(1,6-dioxo-1,6-hexanediyl)bis-D-proline
|
|
AU2015258814B2
(en)
|
2014-05-16 |
2018-04-05 |
Synaptec Development Llc |
Clearance of amyloid ss
|
|
KR102496206B1
(ko)
|
2014-06-11 |
2023-02-06 |
몰레큘러 템플레이츠, 인코퍼레이션. |
프로테아제-절단 저항성의 시가 독소 a 서브유닛 작동체 폴리펩티드 및 이를 포함하는 세포-표적화 분자
|
|
US20150377905A1
(en)
|
2014-06-25 |
2015-12-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for diagnosis of kawasaki disease
|
|
AR100978A1
(es)
|
2014-06-26 |
2016-11-16 |
Hoffmann La Roche |
LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS
|
|
WO2016000156A1
(en)
|
2014-06-30 |
2016-01-07 |
Microsoft Technology Licensing, Llc |
Managing data with flexible schema
|
|
WO2016004093A2
(en)
|
2014-07-01 |
2016-01-07 |
Stealth Biotherapeutics Corp |
Therapeutic compositions including galectin-3 inhibitors and uses thereof
|
|
EP3166688B1
(en)
|
2014-07-08 |
2024-08-21 |
New York University |
Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy
|
|
CN106661103B
(zh)
|
2014-07-10 |
2020-11-03 |
生命北极神经科学公司 |
改进的Aβ初原纤维结合抗体
|
|
PL3177643T3
(pl)
|
2014-08-04 |
2019-09-30 |
F.Hoffmann-La Roche Ag |
Dwuswoiste cząsteczki wiążące antygen aktywujące komórki T
|
|
SMT202100674T1
(it)
|
2014-08-11 |
2022-01-10 |
Acerta Pharma Bv |
Combinazioni terapeutiche di un inibitore di btk e un inibitore di bcl-2
|
|
CN106796243B
(zh)
|
2014-08-14 |
2018-10-12 |
国立大学法人广岛大学 |
判定早产和/或低体重儿生育的风险的方法和用于该方法的试剂盒
|
|
JO3663B1
(ar)
|
2014-08-19 |
2020-08-27 |
Merck Sharp & Dohme |
الأجسام المضادة لمضاد lag3 وأجزاء ربط الأنتيجين
|
|
ES2949173T3
(es)
|
2014-09-15 |
2023-09-26 |
Hoffmann La Roche |
Formulaciones de anticuerpo
|
|
TWI599358B
(zh)
|
2014-09-16 |
2017-09-21 |
美國禮來大藥廠 |
組合療法
|
|
US10328051B2
(en)
|
2014-09-22 |
2019-06-25 |
Zoser B. Salama |
Proline or proline derivatives for the treatment of dementia
|
|
EP3200991B1
(en)
|
2014-10-01 |
2023-12-20 |
Dow Global Technologies LLC |
A multilayer structure and thermoformed articles made therefrom
|
|
US9921230B2
(en)
|
2014-10-08 |
2018-03-20 |
Rhode Island Hospital |
Methods for diagnosis and treatment of concussion or brain injury
|
|
WO2016059453A1
(en)
|
2014-10-16 |
2016-04-21 |
Fundacion Fraunhofer Chile Research |
Biomarkers and therapeutic targets for alzheimer's disease
|
|
AU2015343425A1
(en)
|
2014-11-04 |
2017-05-25 |
Dana-Farber Cancer Institute, Inc. |
Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responses
|
|
EP3221349B1
(en)
|
2014-11-19 |
2020-11-04 |
Axon Neuroscience SE |
Humanized tau antibodies in alzheimer's disease
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
WO2016094639A1
(en)
|
2014-12-10 |
2016-06-16 |
Wisconsin Alumni Research Foundation |
Mini-intronic plasmid dna vaccines in combination with lag3 blockade
|
|
US10464999B2
(en)
|
2015-01-28 |
2019-11-05 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
AU2016210835B2
(en)
|
2015-01-29 |
2021-01-21 |
Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
IL282614B2
(en)
|
2015-02-06 |
2024-02-01 |
Cell Idx Inc |
Antigen-conjugated immune reagents
|
|
AR103713A1
(es)
|
2015-02-26 |
2017-05-31 |
Lilly Co Eli |
Anticuerpos contra tau y sus usos
|
|
GB201504432D0
(en)
|
2015-03-17 |
2015-04-29 |
Electrophoretics Ltd |
Materials and methods for diagnosis and treatment of alzheimers disease
|
|
EP3274010B1
(en)
|
2015-03-27 |
2019-10-02 |
Eliaz Therapeutics, Inc. |
Patient selective apheresis
|
|
GB201505239D0
(en)
|
2015-03-27 |
2015-05-13 |
Neuro Bio Ltd |
Antibody
|
|
US12109346B2
(en)
|
2015-03-27 |
2024-10-08 |
Eliaz Therapeutics, Inc. |
Galectin-3 plasmapheresis therapy
|
|
US10526410B2
(en)
|
2015-04-15 |
2020-01-07 |
Anaptysbio, Inc. |
Antibodies directed against interleukin 36 receptor (IL-36R)
|
|
BR112017023872A2
(pt)
|
2015-05-04 |
2018-07-24 |
Cytomx Therapeutics Inc |
anticorpos anti-cd166, anticorpos anti-cd166 ativáveis e métodos de uso dos mesmos
|
|
CN116196414A
(zh)
|
2015-05-11 |
2023-06-02 |
豪夫迈·罗氏有限公司 |
治疗狼疮性肾炎的组合物和方法
|
|
GB201508276D0
(en)
|
2015-05-14 |
2015-06-24 |
Electrophoretics Ltd |
A casein kinase 1 delta inhibitor
|
|
JP6518917B2
(ja)
|
2015-05-29 |
2019-05-29 |
アッヴィ・インコーポレイテッド |
抗ｃｄ４０抗体およびその使用
|
|
CN114656573B
(zh)
|
2015-05-30 |
2024-09-27 |
分子模板公司 |
去免疫化的志贺毒素a亚基支架和包含它们的细胞靶向分子
|
|
BR112017026027A2
(pt)
|
2015-06-08 |
2018-08-14 |
Debiopharm Int Sa |
combinações de imunoconjugado anti-cd37 e anticorpo anti-cd20
|
|
US10203342B2
(en)
|
2015-06-11 |
2019-02-12 |
Nanosomix, Inc. |
Biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
|
|
AU2016282334B2
(en)
|
2015-06-24 |
2022-07-21 |
F. Hoffmann-La Roche Ag |
Anti-transferrin receptor antibodies with tailored affinity
|
|
ES2809728T3
(es)
|
2015-06-24 |
2021-03-05 |
Hoffmann La Roche |
Anticuerpos anti-tau(pS422) humanizados y procedimientos de uso
|
|
AU2016285868B2
(en)
|
2015-06-30 |
2021-11-11 |
Nanotics, Llc |
Compositions and methods related to scavenger particles
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
EA039859B1
(ru)
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
PT3334761T
(pt)
|
2015-08-13 |
2023-08-17 |
Univ New York |
Moléculas baseadas em anticorpo seletivo para o epítopo {p}ser404 da tau e os seus usos no diagnóstico e tratamento de tauopatias
|
|
US10988528B2
(en)
|
2015-08-13 |
2021-04-27 |
New York University |
Antibody-based molecules specific for the truncated ASP421 epitope of Tau and their uses in the diagnosis and treatment of tauopathy
|
|
ES2992591T3
(en)
|
2015-08-18 |
2024-12-16 |
Rakuten Medical Inc |
Compositions, combinations and related methods for photoimmunotherapy
|
|
IL319047A
(en)
|
2015-08-28 |
2025-04-01 |
Amunix Operating Inc |
Chimeric polypeptide composition and methods for its preparation and use
|
|
EP3347486A4
(en)
|
2015-09-09 |
2019-06-19 |
The Trustees of Columbia University in the City of New York |
REDUCTION OF ER-MAM-LOCALIZED APP-C99 AND METHOD FOR THE TREATMENT OF ALZHEIMER DISEASE
|
|
US20180360959A1
(en)
|
2015-09-25 |
2018-12-20 |
Universität Duisburg-Essen |
Agents inhibiting kallikrein-8 for use in the prevention or treatment of alzheimer's disease
|
|
AU2016332900C1
(en)
|
2015-09-29 |
2024-07-04 |
Amgen Inc. |
ASGR inhibitors
|
|
AR106189A1
(es)
|
2015-10-02 |
2017-12-20 |
Hoffmann La Roche |
ANTICUERPOS BIESPECÍFICOS CONTRA EL A-b HUMANO Y EL RECEPTOR DE TRANSFERRINA HUMANO Y MÉTODOS DE USO
|
|
MX2018003822A
(es)
|
2015-10-02 |
2018-06-22 |
Hoffmann La Roche |
Anticuerpos biespecificos contra el cd20 humano y el receptor de transferrina humano y metodos de uso.
|
|
US11135313B2
(en)
|
2015-10-28 |
2021-10-05 |
The Trustees Of The University Of Pennsylvania |
Intrathecal administration of adeno-associated-viral vectors for gene therapy
|
|
CA3000924A1
(en)
|
2015-11-09 |
2017-05-18 |
Galecto Biotech Ab |
Novel galactoside inhibitors of galectins
|
|
IL313608A
(en)
|
2015-12-09 |
2024-08-01 |
Hoffmann La Roche |
Antibody against CD20 type II to reduce the formation of antibodies against drugs
|
|
CA3007898A1
(en)
|
2015-12-28 |
2017-07-06 |
Innate Pharma |
Variable regions for nkp46 binding proteins
|
|
CN108779182A
(zh)
|
2015-12-28 |
2018-11-09 |
麻省理工学院 |
具有恒定区突变的双特异性抗体及其用途
|
|
JP6884155B2
(ja)
|
2016-02-18 |
2021-06-09 |
エンリヴェックス セラピューティクス リミテッド |
癌治療のための併用免疫療法及びサイトカイン制御療法
|
|
WO2017148880A1
(en)
|
2016-03-01 |
2017-09-08 |
F. Hoffmann-La Roche Ag |
Obinutuzumab variants having altered cell death induction
|
|
SG10202008909VA
(en)
|
2016-03-24 |
2020-10-29 |
Bayer Pharma AG |
Prodrugs of cytotoxic active agents having enzymatically cleavable groups
|
|
CN109069638B
(zh)
|
2016-03-24 |
2022-03-29 |
璟尚生物制药公司 |
用于癌症治疗的三特异性抑制剂
|
|
EP3436010B1
(en)
|
2016-03-29 |
2021-03-10 |
Acadia Pharmaceuticals Inc. |
5-ht2a serotonin receptor inverse agonists or antagonists for use in reducing amyloid-beta peptides and accumulation of amyloid plaques
|
|
AU2017240233B2
(en)
|
2016-03-31 |
2022-07-14 |
University Of Southern California |
A highly sensitive and specific luciferase based reporter assay for antigen detection
|
|
WO2017180587A2
(en)
|
2016-04-11 |
2017-10-19 |
Obsidian Therapeutics, Inc. |
Regulated biocircuit systems
|
|
US11596699B2
(en)
|
2016-04-29 |
2023-03-07 |
CureVac SE |
RNA encoding an antibody
|
|
EP3448874A4
(en)
|
2016-04-29 |
2020-04-22 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
US9933440B2
(en)
|
2016-05-31 |
2018-04-03 |
Edward J. Goetzl |
Drug efficacy test method for dementias utilizing astrocyte-derived exosomes
|
|
US20170363620A1
(en)
|
2016-06-17 |
2017-12-21 |
Abbott Laboratories |
BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
|
|
AU2017290703B2
(en)
|
2016-06-28 |
2023-03-30 |
Emergent Biodefense Operations Lansing Llc |
Formulations of brincidofovir
|
|
JP7029415B2
(ja)
|
2016-07-12 |
2022-03-03 |
ハー・ルンドベック・アクチエゼルスカベット |
過リン酸化タウに特異的な抗体およびその使用方法
|
|
US12123874B2
(en)
|
2016-07-18 |
2024-10-22 |
Cell Idx, Inc. |
Reagent compounds, compositions, kits, and methods for amplified assays
|
|
US10570196B2
(en)
|
2016-07-20 |
2020-02-25 |
Anahit Ghochikyan |
Humanized anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
|
WO2018019188A1
(zh)
|
2016-07-23 |
2018-02-01 |
博瑞生物医药（苏州）股份有限公司 |
核苷氨基磷酸酯类前药的多晶型及其制备方法
|
|
US10076552B2
(en)
|
2016-08-09 |
2018-09-18 |
DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. |
Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
|
|
WO2018030405A1
(ja)
|
2016-08-09 |
2018-02-15 |
国立大学法人東京医科歯科大学 |
Ｈｍｇｂ１に対する抗体、及びそれを含有するアルツハイマー病を治療又は予防するための組成物
|
|
FI3922279T3
(fi)
|
2016-08-30 |
2025-02-04 |
Dana Farber Cancer Inst Inc |
Lääkkeenantokoostumuksia ja niiden käyttötapoja
|
|
WO2018058098A1
(en)
|
2016-09-26 |
2018-03-29 |
Yale University |
Compounds and methods for treating or preventing alzheimer's disease
|
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
EP3324186B1
(en)
|
2016-11-21 |
2020-09-16 |
Ruhr-Universität Bochum |
Method for the preselection of drugs for protein misfolding diseases
|
|
CN110352068A
(zh)
|
2016-12-02 |
2019-10-18 |
南加利福尼亚大学 |
合成的免疫受体及其使用方法
|
|
MX2019006656A
(es)
|
2016-12-07 |
2019-09-09 |
Molecular Templates Inc |
Polipeptidos efectores de la sub-unidad a de la toxina shiga andamiajes de los efectores de la toxina shiga y moleculas con direccion hacia las celulas para la conjugacion especifica del sitio.
|
|
AU2017384528A1
(en)
|
2016-12-19 |
2019-07-04 |
Ichnos Sciences SA |
Novel TNFR agonists and uses thereof
|
|
KR102692708B1
(ko)
|
2016-12-20 |
2024-08-07 |
에프. 호프만-라 로슈 아게 |
항-cd20/항-cd3 이중특이성 항체 및 4-1bb(cd137) 작용물질의 병용 요법
|
|
AU2017380871C1
(en)
|
2016-12-21 |
2025-05-15 |
Bayer Aktiengesellschaft |
Antibody drug conjugates (ADCs) having enzymatically cleavable groups
|
|
US10364286B2
(en)
|
2016-12-22 |
2019-07-30 |
H. Lundbeck A/S |
Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation
|
|
CN118271442A
(zh)
|
2016-12-23 |
2024-07-02 |
蓝鳍生物医药公司 |
抗sez6l2抗体和抗体药物缀合物
|
|
KR102590672B1
(ko)
|
2017-01-25 |
2023-10-18 |
몰레큘러 템플레이츠, 인코퍼레이션. |
탈면역된 시가 독소 a 서브유닛 이펙터 및 cd8+ t-세포 에피토프를 포함하는 세포-표적화 분자
|
|
JP7449092B2
(ja)
|
2017-01-30 |
2024-03-13 |
ナショナル リサーチ カウンシル オブ カナダ |
血液脳関門移動化合物及びその使用
|
|
CN108395482B
(zh)
|
2017-02-08 |
2021-02-05 |
西比曼生物科技（香港）有限公司 |
一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
|
|
US10473672B2
(en)
|
2017-02-09 |
2019-11-12 |
Kaohsiung Chang Gung Memorial Hospital |
Methods for diagnosing and treating Alzheimers disease using G72 protein and SLC7A11 mRNA as biomarkers
|
|
US11319372B2
(en)
|
2017-02-21 |
2022-05-03 |
Remd Biotherapeutics, Inc. |
Cancer treatment using antibodies that bind cytotoxic T-lymphocyte antigen-4 (CTLA-4)
|
|
US20190374650A1
(en)
|
2017-02-22 |
2019-12-12 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of polymer/biomacromolecule conjugates
|
|
CA3056837A1
(en)
|
2017-03-27 |
2018-10-04 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
CN119285787A
(zh)
|
2017-03-31 |
2025-01-10 |
健玛保控股有限公司 |
双特异性抗cd37抗体、单克隆抗cd37抗体及其使用方法
|
|
US20230399414A1
(en)
|
2017-03-31 |
2023-12-14 |
Genmab Holding B.V, |
Bispecific anti-cd37 antibodies, monoclonal anti-cd37 antibodies and methods of use thereof
|
|
MY200973A
(en)
|
2017-04-11 |
2024-01-26 |
Inhibrx Inc |
Multispecific Polypeptide Constructs Having Constrained Cd3 Binding And Methods Of Using The Same
|
|
CN108728465A
(zh)
|
2017-04-14 |
2018-11-02 |
深圳新诺微环生物科技有限公司 |
一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用
|
|
CN110913906A
(zh)
|
2017-05-02 |
2020-03-24 |
默沙东公司 |
抗lag3抗体的制剂和抗lag3抗体与抗pd-1抗体的共制剂
|
|
CN108864290B
(zh)
|
2017-05-08 |
2021-12-07 |
上海津曼特生物科技有限公司 |
双特异性重组蛋白及其应用
|
|
CA3062649A1
(en)
|
2017-05-12 |
2018-11-15 |
Galectin Sciences, Llc |
Compounds for the treatment of systemic insulin resistance disorders and the use thereof
|
|
WO2018210898A1
(en)
|
2017-05-18 |
2018-11-22 |
F. Hoffmann-La Roche Ag |
Reduction of application-related side reaction of a therapeutic antibody
|
|
US10995149B2
(en)
|
2017-06-05 |
2021-05-04 |
Janssen Biotech, Inc. |
Antibodies that specifically bind PD-1 and methods of use
|
|
US11214835B1
(en)
|
2017-06-06 |
2022-01-04 |
University Of South Florida |
Methods and compositions for diagnosis and management of neurodegerative diseases
|
|
US11241485B2
(en)
|
2017-06-12 |
2022-02-08 |
Obsidian Therapeutics, Inc. |
PDE5 compositions and methods for immunotherapy
|
|
US20200306301A1
(en)
|
2017-07-03 |
2020-10-01 |
Torque Therapeutics, Inc. |
Polynucleotides Encoding Immunostimulatory Fusion Molecules and Uses Thereof
|
|
US10662246B2
(en)
|
2017-07-10 |
2020-05-26 |
New York University |
Monoclonal antibody to treat alzheimer's disease, prion disease, frontotemporal dementias and traumatic brain injury/chronic traumatic encephalopathy
|
|
US11220544B2
(en)
|
2017-07-14 |
2022-01-11 |
Cytomx Therapeutics, Inc. |
Anti-CD166 antibodies and uses thereof
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
US20190029970A1
(en)
|
2017-07-31 |
2019-01-31 |
The Chinese University Of Hong Kong |
Fatty acid conjugated nanoparticles and uses thereof
|
|
CN111032039B
(zh)
|
2017-08-03 |
2024-03-26 |
卡莱克汀科学有限责任公司 |
用于预防和治疗医学障碍的化合物及其用途
|
|
AU2018314765C1
(en)
|
2017-08-08 |
2025-11-20 |
Bruker Spatial Biology, Inc. |
Obinutuzumab treatment of a DLBCL patient subgroup
|
|
CN107881160A
(zh)
|
2017-08-11 |
2018-04-06 |
百奥泰生物科技(广州)有限公司 |
一种由基因组被编辑的cho宿主细胞产生的具有独特糖谱的重组抗体及其制备方法
|
|
BR112020005938A2
(pt)
|
2017-09-27 |
2020-11-17 |
University Of Southern California |
célula imune ou população de células imunes da mesma, célula efetora imune ou célula-tronco, célula que apresenta antígeno, polinucleotídeo recombinante, vetor, composição que compreende uma célula imune efetora ou uma célula-tronco, métodos para produzir uma célula efetora imune que expressa receptor imune de ocorrência não natural, para gerar uma população de células manipuladas por rna, para fornecer imunidade antidoença em um indivíduo, para tratar ou prevenir uma doença associada à expressão de um antígeno, e, uso
|
|
EP3466975A1
(en)
|
2017-10-05 |
2019-04-10 |
Laboratoire Français du Fractionnement et des Biotechnologies |
A specific binding molecule directed against galectin-3 protein
|
|
US20200330592A1
(en)
|
2017-10-09 |
2020-10-22 |
Keith Black |
Compositions and methods of treating alzheimer's and other amyloid related diseases
|
|
KR20200067195A
(ko)
|
2017-10-18 |
2020-06-11 |
리젠엑스바이오 인크. |
완전-인간 번역후 변형된 항체 치료제
|
|
JP7252953B2
(ja)
|
2017-10-25 |
2023-04-05 |
エアラン セル テクノロジーズ， インコーポレイテッド |
Ｈ１．０ｋ１８０ｍｅ２抗体、その作製および使用の方法
|
|
JP2021501180A
(ja)
|
2017-10-31 |
2021-01-14 |
ガレクティン・サイエンシーズ・リミテッド・ライアビリティ・カンパニーＧａｌｅｃｔｉｎ Ｓｃｉｅｎｃｅｓ， ＬＬＣ |
全身インスリン抵抗性障害の治療のためのセレノガラクトシド化合物およびその使用
|
|
WO2019094679A1
(en)
|
2017-11-10 |
2019-05-16 |
The Regents Of The University Of California |
BRAIN DELIVERY OF THE BACE INHIBITOR SAPPALPHA, ANTIBODIES, OR INHIBITORY RNA's USING SYNTHETIC EXOSOMES (DEFORMABLE NANOVESICLES, DNVs)
|
|
MA51223A
(fr)
|
2017-11-29 |
2020-10-07 |
Prothena Biosciences Ltd |
Formulation lyophilisée d'un anticorps monoclonal contre la transthyrétine
|
|
IL308604B2
(en)
|
2017-12-06 |
2025-08-01 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|
|
EP3729081B1
(en)
|
2017-12-21 |
2025-02-19 |
F. Hoffmann-La Roche AG |
Car-t cell assay for specificity test of novel antigen binding moieties
|
|
CN109985231A
(zh)
|
2018-01-02 |
2019-07-09 |
上海清流生物医药科技有限公司 |
一种蛋白在制备预防和治疗痴呆症的药物中的应用
|
|
EP3737472A1
(en)
|
2018-01-09 |
2020-11-18 |
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie |
Modulators of c1q, in particular of the interaction of apoe with c1q, and uses of the modulators in the therapy of neuronal diseases and inflammation
|
|
KR101868343B1
(ko)
|
2018-01-16 |
2018-06-18 |
재단법인대구경북과학기술원 |
콧물 시료의 베타 아밀로이드 올리고머를 이용한 알츠하이머 질환의 진행 단계 스크리닝용 조성물 및 이를 이용한 알츠하이머 질환의 진행 단계 스크리닝 방법
|
|
JP7539834B2
(ja)
|
2018-02-01 |
2024-08-26 |
メモリアル スローン ケタリング キャンサー センター |
ガレクチン－３に対する抗体及びその使用方法
|
|
US12398201B2
(en)
|
2018-02-19 |
2025-08-26 |
New York University |
Tau single domain antibodies
|
|
US11819488B2
(en)
|
2018-02-23 |
2023-11-21 |
Rhnanopharma |
Nanosuspensions of salsalate and methods of using the same
|
|
US20210085785A1
(en)
|
2018-02-23 |
2021-03-25 |
Truebinding, Inc. |
Treating cancer by blocking the interaction of vista and its binding partner
|
|
WO2019165421A1
(en)
|
2018-02-26 |
2019-08-29 |
Minerva Biotechnologies Corporation |
Diagnostic methods using anti-muc1* antibodies
|
|
NL2020520B1
(en)
|
2018-03-02 |
2019-09-12 |
Labo Bio Medical Invest B V |
Multispecific binding molecules for the prevention, treatment and diagnosis of neurodegenerative disorders
|
|
AU2019244481A1
(en)
|
2018-03-28 |
2020-10-01 |
Axon Neuroscience Se |
Antibody-based methods of detecting and treating Alzheimer's disease
|
|
CN116173238A
(zh)
|
2018-03-29 |
2023-05-30 |
微脉管治疗有限公司 |
用于检测和治疗阿尔茨海默病的组合物及方法
|
|
WO2019195621A1
(en)
|
2018-04-04 |
2019-10-10 |
Immutics, Inc. |
Methods and compositions for blocking interaction between non-glycosylated pd-1 polypeptides
|
|
TW202010757A
(zh)
|
2018-04-11 |
2020-03-16 |
美商英伊布里克斯公司 |
具有經受限cd3結合的多重特異性多肽構築體以及相關方法及用途
|
|
JP7318948B2
(ja)
|
2018-04-13 |
2023-08-01 |
国立大学法人京都大学 |
微生物由来化合物を用いたアルツハイマー病の予防、治療、または診断薬
|
|
KR102884852B1
(ko)
|
2018-04-16 |
2025-11-14 |
에프. 호프만-라 로슈 아게 |
킬레이트화된 방사성핵종에 대한 항체
|
|
WO2019207159A1
(en)
|
2018-04-27 |
2019-10-31 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
|
US11085935B2
(en)
|
2018-05-03 |
2021-08-10 |
Washington University |
Methods of treating based on site-specific tau phosphorylation
|
|
US20210207167A1
(en)
|
2018-05-16 |
2021-07-08 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
KR102523019B1
(ko)
|
2018-05-30 |
2023-04-18 |
내셔날 헬스 리서치 인스티튜트 |
항-a베타 항체 및 이의 용도
|
|
US20220403001A1
(en)
|
2018-06-12 |
2022-12-22 |
Obsidian Therapeutics, Inc. |
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
PL4094754T3
(pl)
|
2018-06-19 |
2026-01-05 |
Universidad Pablo De Olavide |
Kompozycje do leczenia chorób związanych z agregacją białek i/lub zapobiegania takim chorobom
|
|
EP3810142A4
(en)
|
2018-06-20 |
2022-03-30 |
Sanford Burnham Prebys Medical Discovery Institute |
ANTIRETROVIRAL THERAPIES AND REVERSE TRANSCRIPTASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
|
|
CN113164591A
(zh)
|
2018-07-11 |
2021-07-23 |
动量制药公司 |
与工程化Fc-抗原结合结构域构建体有关的组合物和方法
|
|
WO2020023530A2
(en)
|
2018-07-24 |
2020-01-30 |
Eisai R&D Management Co., Ltd. |
Methods of treatment and prevention of alzheimer's disease
|
|
US12259395B2
(en)
|
2018-08-17 |
2025-03-25 |
Ab Studio Inc. |
Catabodies and methods of use thereof
|
|
WO2020045646A1
(ja)
|
2018-08-31 |
2020-03-05 |
Ｂｌｏｏｍ Ｔｅｃｈｎｏｌｏｇｙ 株式会社 |
終末糖化産物に対する抗体およびその使用
|
|
SG11202102162RA
(en)
|
2018-09-11 |
2021-04-29 |
Univ Washington |
Anti-trem-2 agonist antibodies
|
|
BR112021005086A2
(pt)
|
2018-09-18 |
2021-06-08 |
1Globe Biomedical Co., Ltd. |
tratamento para doença hepática gordurosa não alcoólica
|
|
EP3854875B1
(en)
|
2018-09-21 |
2026-01-14 |
Institute of Science Tokyo |
Human monoclonal antibody binding specifically to human hmgb1, and pharmaceutical composition for treating or preventing alzheimer's disease containing said human monoclonal antibody
|
|
KR102862077B1
(ko)
|
2018-10-04 |
2025-09-18 |
게오르그-아우구스트-우니베시태트 괴팅겐 스티프퉁 외펜틀리헨 레흐츠, 우니베시태츠메디진 |
인간화 항-n-절단 아밀로이드 베타 단일 클론 항체
|
|
WO2020069621A1
(en)
|
2018-10-04 |
2020-04-09 |
University Of Manitoba |
Novel biomarker for alzheimer's disease in human
|
|
AU2019356573B2
(en)
|
2018-10-11 |
2025-12-18 |
Inhibrx Biosciences, Inc. |
PD-1 single domain antibodies and therapeutic compositions thereof
|
|
JP2022505101A
(ja)
|
2018-10-18 |
2022-01-14 |
ファンダメンタル ファーマ ゲーエムベーハー |
Ｎｍｄａ受容体媒介毒性を調節するための新規の方法
|
|
EP3643319A1
(en)
|
2018-10-25 |
2020-04-29 |
Grifols Worldwide Operations Limited |
Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages
|
|
MA54070A
(fr)
|
2018-10-29 |
2021-09-08 |
Biogen Ma Inc |
Variants fc5 humanisés et stabilisés pour l'amélioration du transport à travers la barrière hémato-encéphalique
|
|
EP3873604B1
(en)
|
2018-10-29 |
2024-08-21 |
Cyclo Therapeutics, Inc. |
Methods for treating alzheimer's disease with hp-[beta]-cyclodextrin
|
|
EP3878869A4
(en)
|
2018-11-07 |
2023-04-19 |
Shanghai Hyamab Biotech Co., Ltd. |
NKG2A ANTIBODIES, METHOD OF PRODUCTION THEREOF AND USE THEREOF
|
|
CN113302206A
(zh)
|
2018-11-26 |
2021-08-24 |
戴纳立制药公司 |
治疗脂质代谢失调的方法
|
|
JP2022510218A
(ja)
|
2018-11-30 |
2022-01-26 |
メモリアル スローン ケタリング キャンサー センター |
ヘテロ二量体四価特異性抗体およびこれらの使用
|
|
EP3890618A4
(en)
|
2018-12-04 |
2023-01-11 |
The Brain Protection Company PTY Ltd |
COMBINATIONAL THERAPIES COMPRISING IMPLANTABLE DAMPING DEVICES AND THERAPEUTIC AGENTS FOR TREATING A CONDITION AND SYSTEMS AND METHODS OF USE THEREOF
|
|
WO2020123492A1
(en)
|
2018-12-10 |
2020-06-18 |
New York University |
Monoclonal antibodies targeting c-terminal region of phosphorylated tau
|
|
CR20210326A
(es)
|
2018-12-21 |
2021-09-10 |
Hoffmann La Roche |
Moléculas agonistas de unión al antígeno cd28 que actúan sobre el tumor
|
|
JP2022037257A
(ja)
|
2018-12-27 |
2022-03-09 |
クリニジェン株式会社 |
アルツハイマー病を治療又は予防する為の抗ウイルス剤及びその使用
|
|
EP3911371A4
(en)
|
2019-01-18 |
2023-04-26 |
University of Southern California |
METHODS AND COMPOSITIONS FOR IMPROVING THE SAFETY AND EFFICACY OF CELL THERAPY
|
|
WO2020154475A1
(en)
|
2019-01-23 |
2020-07-30 |
Molecular Templates, Inc. |
Proteins comprising modified immunoglobulin variable light chains
|
|
KR20210124308A
(ko)
|
2019-01-30 |
2021-10-14 |
트루바인딩 아이엔씨. |
항-gal3 항체 및 이의 용도
|
|
CN111518205B
(zh)
|
2019-02-01 |
2022-03-29 |
长春金赛药业有限责任公司 |
人源化抗Aβ单克隆抗体及其应用
|
|
SG11202106717PA
(en)
|
2019-02-08 |
2021-07-29 |
Prothena Biosciences Ltd |
Antibodies recognizing tau
|
|
SG11202108312PA
(en)
|
2019-02-08 |
2021-08-30 |
Ac Immune Sa |
Method of safe administration of phosphorylated tau peptide vaccine
|
|
PL240124B1
(pl)
|
2019-02-21 |
2022-02-21 |
Univ Jagiellonski |
Sposób określania stopnia uszkodzenia nerek pojawiającego się u chorych z cukrzycą
|
|
AU2020225631A1
(en)
|
2019-02-22 |
2021-09-16 |
Memorial Sloan Kettering Cancer Center |
CD33 antibodies and methods of using the same to treat cancer
|
|
WO2020176672A1
(en)
|
2019-02-26 |
2020-09-03 |
Cytomx Therapeutics, Inc. |
Combined therapies of activatable immune checkpoint inhibitors and conjugated activatable antibodies
|
|
US20220160710A1
(en)
|
2019-03-08 |
2022-05-26 |
University Of Virginia Patent Foundation |
Compositions and methods for treating or preventing alzheimer's disease
|
|
AU2020240310A1
(en)
|
2019-03-21 |
2021-10-07 |
Immunogen, Inc. |
Methods of preparing cell-binding agent-drug conjugates
|
|
SG11202110504XA
(en)
|
2019-03-26 |
2021-10-28 |
Janssen Pharmaceutica Nv |
ANTIBODIES TO PYROGLUTAMATE AMYLOID-ß AND USES THEREOF
|
|
AU2020253356A1
(en)
|
2019-03-29 |
2021-10-28 |
Torque Therapeutics, Inc. |
Immunotherapeutic compositions and use thereof
|
|
US20230094471A1
(en)
|
2019-03-29 |
2023-03-30 |
Immunogen, Inc. |
Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for inhibiting abnormal cell growth or for treating proliferative diseases
|
|
MX2021012336A
(es)
|
2019-04-08 |
2021-11-12 |
Phanes Therapeutics Inc |
Receptores de antigeno quimerico anti-dll3 humanizados y usos de los mismos.
|
|
MX2021012994A
(es)
|
2019-04-24 |
2022-03-04 |
Janssen Pharmaceuticals Inc |
Administracion heterologa de vacunas tau.
|
|
US20220195462A1
(en)
|
2019-04-24 |
2022-06-23 |
Regenxbio Inc. |
Fully-human post-translationally modified antibody therapeutics
|
|
RS64961B1
(sr)
|
2019-04-26 |
2024-01-31 |
Immunogen Inc |
Derivati kamptotecina
|
|
DE202020006093U1
(de)
|
2019-05-06 |
2025-04-09 |
The Regents Of The University Of California |
Nicht-HLA-Marker der Transplantatabstoßung
|
|
CN114040772A
(zh)
|
2019-05-09 |
2022-02-11 |
约翰内斯堡威特沃特斯兰德大学 |
降低Tau(τ)蛋白和/或磷酸化Tau(τ)蛋白的浓度的方法
|
|
BR112021022815A2
(pt)
|
2019-05-14 |
2021-12-28 |
Genentech Inc |
Métodos para tratar linfoma folicular, kits, imunoconjugados e polatuzumabe vedotina
|
|
WO2020236679A1
(en)
|
2019-05-17 |
2020-11-26 |
Cytomx Therapeutics, Inc. |
Methods and compositions for determining the biodistribution of activatable anti-cd166 antibody conjugates
|
|
KR20220042055A
(ko)
|
2019-06-04 |
2022-04-04 |
베르조 테라퓨틱스, 아이엔씨. |
골수성 세포 염증성 표현형을 조절하기 위한 항-psgl-1 조성물 및 방법, 그리고 이의 용도
|
|
CN116987197A
(zh)
|
2019-06-20 |
2023-11-03 |
成都恩沐生物科技有限公司 |
共价多特异性抗体
|
|
WO2020257745A1
(en)
|
2019-06-21 |
2020-12-24 |
University Of Kansas |
Compositions and methods useful in treating brain diseases
|
|
WO2020264200A1
(en)
|
2019-06-26 |
2020-12-30 |
Amunix Pharmceuticals, Inc. |
Cd3 antigen binding fragments and compositions comprising same
|
|
US20220251192A1
(en)
|
2019-06-26 |
2022-08-11 |
Memorial Sloan Kettering Cancer Center |
Anti-cd33 antibodies for treating cancer
|
|
CN114269379A
(zh)
|
2019-06-28 |
2022-04-01 |
加利福尼亚大学董事会 |
用于治疗阿尔茨海默病的方法和组合物
|
|
EP3995582B1
(en)
|
2019-07-01 |
2026-04-22 |
Eisai R&D Management Co., Ltd. |
Anti-epha4 antibody
|
|
WO2021007110A1
(en)
|
2019-07-05 |
2021-01-14 |
University Of Florida Research Foundation, Incorporated |
Methods for treating ran protein-associated neurological diseases
|
|
JP7194085B2
(ja)
|
2019-07-09 |
2022-12-21 |
日立Astemo株式会社 |
操舵制御装置、操舵制御方法、及び操舵制御システム
|
|
WO2021009646A1
(en)
|
2019-07-15 |
2021-01-21 |
Cochlear Limited |
Transcutaneous power and data communication link
|
|
CA3313684A1
(en)
|
2019-07-16 |
2026-06-21 |
Sanofi |
Neutralizing anti-amyloid beta antibodies for the treatment of alzheimer's disease
|
|
DE102019119426A1
(de)
|
2019-07-17 |
2021-01-21 |
Endress+Hauser SE+Co. KG |
Feldgerät der Automatisierungstechnik
|
|
EP4002490A4
(en)
|
2019-07-17 |
2023-04-05 |
Kabushiki Kaisha Toshiba |
SOLAR BATTERY MODULE AND TANDEM SOLAR BATTERY
|
|
WO2021012082A1
(zh)
|
2019-07-19 |
2021-01-28 |
莫丁丁 |
β—淀粉样蛋白环状核糖核酸、多肽及其应用
|
|
CN114929738B
(zh)
|
2019-08-07 |
2026-01-02 |
水肺治疗公司 |
抗nampt抗体及其用途
|
|
KR20220061126A
(ko)
|
2019-08-14 |
2022-05-12 |
베링거 인겔하임 에르체파우 게엠베하 운트 코 카게 |
카스파제-2 변이체
|
|
CN114650867A
(zh)
|
2019-08-30 |
2022-06-21 |
齐鲁普吉湾生物治疗公司 |
抗cd20抗体、抗cd37抗体及它们的混合物
|
|
US12551560B2
(en)
|
2019-09-09 |
2026-02-17 |
Scribe Therapeutics Inc. |
Compositions and methods for use in immunotherapy
|
|
JP2022547513A
(ja)
|
2019-09-09 |
2022-11-14 |
アクソン ニューロサイエンス エスエー |
アルツハイマー病及び軽度認知障害のバイオマーカー及び治療
|
|
US20220340677A1
(en)
|
2019-09-09 |
2022-10-27 |
Wuhan Yzy Biopharma Co., Ltd. |
Split intein and preparation method for recombinant polypeptide using the same
|
|
ES3064633T3
(en)
|
2019-09-12 |
2026-04-28 |
Hoffmann La Roche |
Compositions and methods of treating lupus nephritis
|
|
US11202068B2
(en)
|
2019-09-16 |
2021-12-14 |
Mediatek Inc. |
Method and apparatus of constrained cross-component adaptive loop filtering for video coding
|
|
BR112022005044A2
(pt)
|
2019-09-17 |
2022-07-05 |
Ohio State Innovation Foundation |
Peptídeo quimérico, peptídeo sintético, composição farmacêutica, anticorpo, método de tratamento
|
|
CA3151237A1
(en)
|
2019-09-19 |
2021-03-25 |
Ramesh Baliga |
Multimeric antibodies with enhanced selectivity for cells with high target density
|
|
AU2020356896B2
(en)
|
2019-10-04 |
2026-07-30 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibitor of cell proliferation in obinutuzumab resistant CD20-positive cancer, and medicinal composition, medicine, production, method for inhibiting cell proliferation, therapeutic method, type II anti-CD20 antibody, compounds, combination of same, enhancer and inducer, each relating thereto
|
|
US20240050529A1
(en)
|
2019-10-07 |
2024-02-15 |
University Of Virginia Patent Foundation |
Modulating lymphatic vessels in neurological disease
|
|
CN112641953A
(zh)
|
2019-10-10 |
2021-04-13 |
复旦大学 |
一种靶向功能分子修饰的抗体复合物
|
|
CN114599393A
(zh)
|
2019-10-22 |
2022-06-07 |
比奥根Ma公司 |
治疗阿尔茨海默病的抗β-淀粉样蛋白抗体
|
|
ES2821599A1
(es)
|
2019-10-24 |
2021-04-26 |
Univ Del Pais Vasco / Euskal Herriko Unibertsitatea |
Compuestos y metodos para el tratamiento de la enfermedad de alzheimer
|
|
WO2021087245A1
(en)
|
2019-10-30 |
2021-05-06 |
The Texas A&M University System |
Protease switch for dual targets chimeric antigen receptor t cell therapy
|
|
GB201915855D0
(en)
|
2019-10-31 |
2019-12-18 |
Univ Oxford Innovation Ltd |
An extracellular vesicle
|
|
EP4058466A1
(en)
|
2019-11-13 |
2022-09-21 |
Amunix Pharmaceuticals, Inc. |
Barcoded xten polypeptides and compositions thereof, and methods for making and using the same
|
|
EP4574982A3
(en)
|
2019-11-28 |
2025-11-26 |
McMaster University |
Recombinant polypeptides for programming extracellular vesicles
|
|
CN115279789A
(zh)
|
2019-12-06 |
2022-11-01 |
真和制药有限公司 |
破坏gal3和胰岛素受体或整联蛋白的相互作用的抗体及其使用方法
|
|
US20230046007A1
(en)
|
2019-12-17 |
2023-02-16 |
Cirlo Gmbh |
Tubular shaped elongated catheter device assemblies for interacting with components of bodily fluids, method for recovering cells, cell aggregates and exosomes from a tubular shaped elongated catheter device and smart tubular shaped elongated catheter device assemblies for monitoring interaction with components of bodily fluids
|
|
EP4085251B1
(en)
|
2020-01-02 |
2024-07-31 |
F. Hoffmann-La Roche AG |
Method for determining the amount of a therapeutic antibody in the brain
|
|
CN119930824A
(zh)
|
2020-01-13 |
2025-05-06 |
真和制药有限公司 |
抗Gal3抗体和使用方法
|
|
JP7692918B6
(ja)
|
2020-01-21 |
2025-07-17 |
上海復宏漢霖生物技術股▲フン▼有限公司 |
抗ｌａｇ３モノクローナル抗体、その製造方法および使用
|
|
EP4097129A1
(en)
|
2020-01-29 |
2022-12-07 |
Inhibrx, Inc. |
Cd28 single domain antibodies and multivalent and multispecific constructs thereof
|
|
AU2021217290A1
(en)
|
2020-02-05 |
2022-07-21 |
Sumitomo Pharma Co., Ltd. |
Determination agent and determination method for tauopathy and dementia-related diseases
|
|
EP4103618A4
(en)
|
2020-02-12 |
2024-05-01 |
The Scripps Research Institute |
LONG-ACTING GM-CSF AND METHODS OF USE
|
|
WO2021163681A2
(en)
|
2020-02-14 |
2021-08-19 |
The Trustees Of Columbia University In The City Of New York |
Combination of retromer pharmacological chaperones and exogenous retromer for the treatment of alzheimer's disease and other neurodegenerative diseases and disorders
|
|
WO2021167723A1
(en)
|
2020-02-17 |
2021-08-26 |
Board Of Regents, The University Of Texas System |
Chimeric scavenger receptors targeted to phosphorylated tau (ptau) and uses thereof
|
|
KR20220149606A
(ko)
|
2020-03-02 |
2022-11-08 |
더 리전츠 오브 더 유니버시티 오브 캘리포니아 |
암 치료를 위한 키메라 항원 수용체 및 관련 방법 및 조성물
|
|
GB202003428D0
(en)
|
2020-03-10 |
2020-04-22 |
Univ Dundee |
IL-10 mutiens
|
|
CN113384710A
(zh)
|
2020-03-14 |
2021-09-14 |
杭州星鳌生物科技有限公司 |
新型免疫激动剂复合物的组成及其在抗多种疾病药物中的应用
|
|
WO2021188599A1
(en)
|
2020-03-16 |
2021-09-23 |
University Of Southern California |
Novel antigen binding domains and synthetic antigen receptors incorporating the same
|
|
CN113402612A
(zh)
|
2020-03-17 |
2021-09-17 |
西比曼生物科技（香港）有限公司 |
靶向cd19和cd20的联合嵌合抗原受体及其应用
|
|
US20230104705A1
(en)
|
2020-03-17 |
2023-04-06 |
Cellular Biomedicine Group Inc. |
Combined chimeric antigen receptor targeting cd19 and cd20 and application thereof
|
|
US20230212255A1
(en)
|
2020-03-17 |
2023-07-06 |
Cellular Biomedicine Group Inc. |
Combined chimeric antigen receptor targeting cd19 and cd20 and applications thereof
|
|
US20230143984A1
(en)
|
2020-03-20 |
2023-05-11 |
Heidelberg University |
Colloidal carrier systems for transfer of agents to a desired site of action
|
|
EP4125937A4
(en)
|
2020-03-23 |
2024-05-22 |
G3P, Inc. |
METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING FIBROSIS DUE TO CORONAVIRUS INFECTION
|
|
CN115666625A
(zh)
|
2020-03-24 |
2023-01-31 |
泰伦基国际有限公司 |
一种促进错误折叠蛋白及其聚集物降解的方法和药物
|
|
US20230173039A1
(en)
|
2020-03-24 |
2023-06-08 |
Talengen International Limited |
Method and drug for treating alzheimer disease
|
|
US20230141177A1
(en)
|
2020-03-31 |
2023-05-11 |
The University Of British Columbia |
Antibodies to misfolded amyloid beta
|
|
JP7792346B2
(ja)
|
2020-04-07 |
2025-12-25 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
中枢神経系及び非中枢神経系への治療薬の送達のための合成エキソソームの製造
|
|
CA3174646A1
(en)
|
2020-04-07 |
2021-10-14 |
Pieter Muntendam |
Methods and compositions for preventing and treating retinal nerve damage
|
|
CN115702003A
(zh)
|
2020-04-23 |
2023-02-14 |
瑞美德生物医药科技有限公司 |
趋化因子受体4(cxcr4)拮抗剂抗体
|
|
MX2022013198A
(es)
|
2020-04-24 |
2022-11-14 |
Genentech Inc |
Metodos de uso de inmunoconjugados anti-cd79b.
|
|
MX2022013173A
(es)
|
2020-04-24 |
2022-11-30 |
Hoffmann La Roche |
Modulacion de enzimas y vias con compuestos de sulfhidrilo y sus derivados.
|
|
AU2021276401A1
(en)
|
2020-05-19 |
2022-12-15 |
Othair Prothena Limited |
Multi-epitope vaccine for the treatment of Alzheimer's disease
|
|
MX2022014786A
(es)
|
2020-05-26 |
2023-01-16 |
Truebinding Inc |
Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.
|
|
EP4157241A4
(en)
|
2020-05-29 |
2025-01-08 |
The Regents of the University of California |
AGENTS AND METHODS FOR THE TREATMENT OF TAUOPATHIES
|
|
CN116529260A
(zh)
|
2020-06-02 |
2023-08-01 |
当康生物技术有限责任公司 |
抗cd93构建体及其用途
|
|
WO2021247769A1
(en)
|
2020-06-02 |
2021-12-09 |
Dynamicure Biotechnology Llc |
Anti-cd93 constructs and uses thereof
|
|
TWI843503B
(zh)
|
2020-06-03 |
2024-05-21 |
美商基利科學股份有限公司 |
Lpa受體拮抗劑及其用途
|
|
WO2021248081A1
(en)
|
2020-06-05 |
2021-12-09 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Acvr1 (alk2) receptor inhibition to treat neurological diseases
|
|
KR102225447B1
(ko)
|
2020-06-16 |
2021-03-08 |
부산대학교 산학협력단 |
구강 세균의 군집을 이용한 알츠하이머 진단용 바이오마커 및 이의 용도
|
|
CA3176552A1
(en)
|
2020-06-19 |
2021-12-23 |
F. Hoffmann-La Roche Ag |
Immune activating fc domain binding molecules
|
|
TWI916375B
(zh)
|
2020-06-25 |
2026-03-01 |
英商梅迪繆思有限公司 |
軸突損傷之預防
|
|
US20210403644A1
(en)
|
2020-06-29 |
2021-12-30 |
University Of South Carolina |
Method For The Degradation Of Endogenous Protein
|
|
JP7859975B2
(ja)
|
2020-06-30 |
2026-05-15 |
塩野義製薬株式会社 |
抗ｃｃｒ８抗体と化学療法剤の併用
|
|
AU2021304372A1
(en)
|
2020-07-10 |
2023-03-02 |
Biomolecular Holdings Llc |
Tetrahedral antibodies
|
|
KR20230085904A
(ko)
|
2020-07-20 |
2023-06-14 |
네오티엑스 테라퓨틱스 엘티디. |
암을 치료하기 위한 방법 및 조성물에 사용하기 위한 초항원 접합체
|
|
CN116324416A
(zh)
|
2020-07-20 |
2023-06-23 |
基因泰克公司 |
用于自中而下抗体表征的方法
|
|
MX2023000859A
(es)
|
2020-07-21 |
2023-04-19 |
Amunix Pharmaceuticals Inc |
Composiciones y metodos relacionados con agentes terapeuticos activables.
|
|
IL300121A
(en)
|
2020-07-29 |
2023-03-01 |
Dynamicure Biotechnology Llc |
Anti-cd93 constructs and uses thereof
|
|
WO2022026832A1
(en)
|
2020-07-30 |
2022-02-03 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for ichthyosis
|
|
CA3187750A1
(en)
|
2020-07-30 |
2022-02-03 |
Mesfin Yimam |
A standardized bioflavonoid composition for regulation of homeostasis of host defense mechanism
|
|
WO2022029051A1
(en)
|
2020-08-03 |
2022-02-10 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
JP7904195B2
(ja)
|
2020-08-03 |
2026-08-12 |
ジェネンテック， インコーポレイテッド |
リンパ腫のための診断及び治療方法
|
|
CN116472055A
(zh)
|
2020-08-07 |
2023-07-21 |
欧萨尔普罗席纳有限公司 |
治疗阿尔兹海默氏病的多表位疫苗
|
|
IL300346A
(en)
|
2020-08-07 |
2023-04-01 |
Prothena Biosciences Ltd |
TAU vaccine for the treatment of Alzheimer's disease
|
|
KR102799318B1
(ko)
|
2020-08-11 |
2025-04-23 |
주식회사 카나프테라퓨틱스 |
Il-12 및 항-fap 항체를 포함하는 융합단백질 및 이의 용도
|
|
JP7610302B2
(ja)
|
2020-08-28 |
2025-01-08 |
ハーバー・バイオメド・（シャンハイ）・カンパニー・リミテッド |
Ｃｃｒ８抗体及びその用途
|
|
JP7510518B2
(ja)
|
2020-09-01 |
2024-07-03 |
レメゲン シーオー．，エルティーディー． |
抗ｃ－Ｍｅｔ抗体薬物複合体及びその応用
|
|
CN116724046A
(zh)
|
2020-09-17 |
2023-09-08 |
欧萨尔普罗席纳有限公司 |
用于治疗阿尔茨海默病之β淀粉样蛋白疫苗
|
|
EP4213946A1
(en)
|
2020-09-18 |
2023-07-26 |
Pieris Pharmaceuticals GmbH |
Biomarker methods and uses
|
|
WO2022060488A1
(en)
|
2020-09-18 |
2022-03-24 |
Othair Prothena Limited |
Multiepitope vaccine for the treatment of alzheimer's disease
|
|
IL300543A
(en)
|
2020-09-24 |
2023-04-01 |
Hoffmann La Roche |
Prevention or reduction of adverse effects associated with a bispecific T-cell antibody
|
|
WO2022072538A1
(en)
|
2020-09-30 |
2022-04-07 |
Biotheryx, Inc. |
Antibody-drug conjugates, pharmaceutical compositions thereof, and their therapeutic applications
|
|
EP4225373A4
(en)
|
2020-10-07 |
2025-01-08 |
Dren Bio, Inc. |
ANTI-DECTIN-1 ANTIBODIES AND METHODS OF USE THEREOF
|
|
AU2021277712B2
(en)
|
2020-10-16 |
2023-05-25 |
LaNova Medicines Limited |
Anti-CCR8 monoclonal antibodies and uses thereof
|
|
AR124562A1
(es)
|
2020-10-28 |
2023-04-12 |
Hoffmann La Roche |
Receptores de unión al antígeno mejorada
|
|
IL302570A
(en)
|
2020-11-10 |
2023-07-01 |
Hoffmann La Roche |
Prevention or reduction of adverse effects associated with the T-CELL agent
|
|
US12655221B2
(en)
|
2020-12-08 |
2026-06-16 |
Memorial Sloan Kettering Cancer Center |
Antibodies to galectin-3 and methods of use thereof
|
|
CN114656562B
(zh)
|
2020-12-23 |
2023-11-03 |
北京天广实生物技术股份有限公司 |
结合人和猴cd3的抗体及其应用
|
|
CN116829598A
(zh)
|
2021-01-06 |
2023-09-29 |
豪夫迈·罗氏有限公司 |
采用pd1-lag3双特异性抗体和cd20 t细胞双特异性抗体的组合疗法
|
|
WO2022150644A1
(en)
|
2021-01-08 |
2022-07-14 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for acne
|
|
WO2022150642A1
(en)
|
2021-01-08 |
2022-07-14 |
Anaptysbio, Inc. |
Anti-interleukin 36 receptor (il-36r) therapy for hidradenitis suppurativa
|
|
EP4284824A4
(en)
|
2021-01-27 |
2025-03-12 |
AbelZeta Inc. |
CHIMERIC ANTIGEN RECEPTORS TARGETING CD20
|
|
WO2022164288A1
(ko)
|
2021-01-29 |
2022-08-04 |
한국과학기술원 |
비염증성 식세포작용 유도 활성을 갖는 융합분자
|
|
IL305175A
(en)
|
2021-02-19 |
2023-10-01 |
Angeles Therapeutics Inc |
Single-chain and multi-chain synthetic antigen receptors for diverse immune cells
|
|
EP4454652A3
(en)
|
2021-03-15 |
2025-05-21 |
F. Hoffmann-La Roche AG |
Compositions and methods for treating lupus nephritis
|
|
IL305886A
(en)
|
2021-03-18 |
2023-11-01 |
Seagen Inc |
Selective release of drugs from internalized conjugates of biologically active compounds
|
|
JP2024510435A
(ja)
|
2021-03-18 |
2024-03-07 |
シージェン インコーポレイテッド |
生体活性化合物の内部移行複合体からの選択的薬物放出
|
|
CN117355319A
(zh)
|
2021-03-23 |
2024-01-05 |
皮里斯制药有限责任公司 |
用于癌症治疗的her2/4-1bb双特异性融合蛋白
|
|
CA3212978A1
(en)
|
2021-03-24 |
2022-09-29 |
James N. KOCHENDERFER |
Bicistronic chimeric antigen receptors designed to reduce retroviral recombination and uses thereof
|
|
WO2022200478A1
(en)
|
2021-03-24 |
2022-09-29 |
Pieris Pharmaceuticals Gmbh |
Tumor treatment with a 4-1bb/her2-bispecific agent and a her2-targeted tyrosine kinase inhibitor
|
|
CN117321087A
(zh)
|
2021-03-26 |
2023-12-29 |
先天制药公司 |
包含与细胞因子融合用于nk细胞衔接的nkp46结合位点、癌抗原结合位点的多特异性蛋白质
|
|
US20240182584A1
(en)
|
2021-04-02 |
2024-06-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Bispecific Molecules and Related Compositions and Methods
|
|
CA3212610A1
(en)
|
2021-04-20 |
2022-10-27 |
Philip MOQUIST |
Modulation of antibody-dependent cellular cytotoxicity
|
|
JP2024514281A
(ja)
|
2021-04-23 |
2024-04-01 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
Ｎｋ細胞係合剤関連の有害作用の防止または軽減
|
|
JP2024515968A
(ja)
|
2021-04-26 |
2024-04-11 |
トゥルーバインディング，インコーポレイテッド |
抗ｇａｌ３抗体製剤およびその使用法
|
|
WO2022228706A1
(en)
|
2021-04-30 |
2022-11-03 |
F. Hoffmann-La Roche Ag |
Dosing for treatment with anti-cd20/anti-cd3 bispecific antibody
|
|
CA3213632A1
(en)
|
2021-04-30 |
2022-11-03 |
F. Hoffmann-La Roche Ag |
Dosing for combination treatment with anti-cd20/anti-cd3 bispecific antibody and anti-cd79b antibody drug conjugate
|
|
WO2022235622A2
(en)
|
2021-05-04 |
2022-11-10 |
Biocove Llc |
Cd20 targeting fusion proteins and methods of use thereof
|
|
EP4337266A1
(en)
|
2021-05-12 |
2024-03-20 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma
|
|
US20240285740A1
(en)
|
2021-05-12 |
2024-08-29 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating cancer
|
|
EP4337257A1
(en)
|
2021-05-12 |
2024-03-20 |
AnaptysBio, Inc. |
Antibody composition
|
|
IL308795A
(en)
|
2021-05-28 |
2024-01-01 |
Seagen Inc |
Anthracycline antibody conjugates
|
|
AR126009A1
(es)
|
2021-06-02 |
2023-08-30 |
Hoffmann La Roche |
Moléculas agonistas de unión al antígeno cd28 que se dirigen a epcam
|
|
CN118139641A
(zh)
|
2021-06-04 |
2024-06-04 |
Xencor股份有限公司 |
结合cd20和cd3的双重特异性抗体的剂量施用
|
|
CN117897406A
(zh)
|
2021-06-08 |
2024-04-16 |
真和制药有限公司 |
抗gal3抗体及其用于胰岛素抵抗的方法
|
|
EP4352108A4
(en)
|
2021-06-09 |
2026-01-07 |
Shanghai Epimab Biotherapeutics Co Ltd |
BISPECIFIC ANTIBODIES AND BINDING PROTEINS THAT BIND TO OX40 AND/OR PD-L1 MOLECULES
|
|
CN117616050A
(zh)
|
2021-06-09 |
2024-02-27 |
先天制药公司 |
与nkp46、细胞因子受体、肿瘤抗原和cd16a结合的多特异性蛋白质
|
|
WO2022258678A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkp30, a cytokine receptor, a tumour antigen and cd16a
|
|
WO2022258691A1
(en)
|
2021-06-09 |
2022-12-15 |
Innate Pharma |
Multispecific proteins binding to nkg2d, a cytokine receptor, a tumour antigen and cd16a
|
|
KR20240019786A
(ko)
|
2021-06-09 |
2024-02-14 |
이나뜨 파르마 에스.에이. |
Cd20, nkp46, cd16에 결합하고 il-2에 접합된 다중특이적 항체
|
|
CA3222880A1
(en)
|
2021-06-18 |
2022-12-22 |
Jeffrey Stavenhagen |
Antibodies which bind human fibrin or fibrinogen ?c domain and methods of use
|
|
JP2024522237A
(ja)
|
2021-06-18 |
2024-06-11 |
セリーニ バイオ インコーポレイテッド |
ヒトフィブリンまたはフィブリノゲンγＣドメインに結合する抗体および使用方法
|
|
WO2022268050A1
(zh)
|
2021-06-22 |
2022-12-29 |
荣昌生物制药(烟台)股份有限公司 |
一种药物组合及其用途
|
|
KR20240025013A
(ko)
|
2021-06-25 |
2024-02-26 |
난징 이뮤노파지 바이오테크 코., 엘티디. |
항-ccr8 항체 및 이의 용도
|
|
WO2023281482A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Cd20-targeted il-2 and its uses
|
|
US20230201364A1
(en)
|
2021-07-09 |
2023-06-29 |
Bright Peak Therapeutics Ag |
Antibody conjugates and manufacture thereof
|
|
WO2023287663A1
(en)
|
2021-07-13 |
2023-01-19 |
Genentech, Inc. |
Multi-variate model for predicting cytokine release syndrome
|
|
JP2024526764A
(ja)
|
2021-07-13 |
2024-07-19 |
トゥルーバインディング，インコーポレイテッド |
タンパク質凝集を防止する方法
|
|
EP4370541A1
(en)
|
2021-07-14 |
2024-05-22 |
2seventy bio, Inc. |
Engineered t cell receptors fused to binding domains from antibodies
|
|
JP2024528631A
(ja)
|
2021-07-22 |
2024-07-30 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
ヘテロ二量体Ｆｃドメイン抗体
|
|
US20240336697A1
(en)
|
2021-08-07 |
2024-10-10 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma
|
|
US20240353426A1
(en)
|
2021-08-13 |
2024-10-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for Diagnosing and Treating Ischemic Eye Disease
|
|
TW202330594A
(zh)
|
2021-09-29 |
2023-08-01 |
美商莫德斯醫療公司 |
抗原結合多肽、抗原結合多肽複合物及其使用方法
|
|
CN118317979A
(zh)
|
2021-09-29 |
2024-07-09 |
摩德斯医疗股份有限公司 |
抗原结合多肽、抗原结合多肽复合物及其使用方法
|
|
CN115894701A
(zh)
|
2021-09-30 |
2023-04-04 |
上海君实生物医药科技股份有限公司 |
结合cd3的抗体及其用途
|
|
AR127271A1
(es)
|
2021-10-09 |
2024-01-03 |
Hutchmed Ltd |
Anticuerpos biespecíficos que se unen específicamente a cd47 y cd20, y usos de los mismos
|
|
CN115746134A
(zh)
|
2021-10-15 |
2023-03-07 |
深圳市睿盟创新生物科技有限公司 |
半乳糖凝集素-3的免疫测定
|
|
KR102963172B1
(ko)
|
2021-10-22 |
2026-05-18 |
상트네어바이오사이언스 주식회사 |
두개의 Fc 도메인을 포함하는 항원 결합 단백질 및 이의 용도
|
|
WO2023077099A1
(en)
|
2021-10-29 |
2023-05-04 |
Zielbio, Inc. |
Cancer specific plectin-1 specific antibodies and methods of use thereof
|
|
US20230279120A1
(en)
|
2021-11-09 |
2023-09-07 |
Truebinding, Inc. |
Methods of treating or inhibiting cardiovascular diseases
|
|
CA3237616A1
(en)
|
2021-11-25 |
2023-06-01 |
F. Hoffmann-La Roche Ag |
Improved antigen binding receptors
|
|
US20250108123A1
(en)
|
2021-12-17 |
2025-04-03 |
Jacobio Pharmaceuticals Co., Ltd. |
Compound-linker constructs comprising novel compounds useful as sting agonists and uses thereof
|
|
CN119930823A
(zh)
|
2021-12-23 |
2025-05-06 |
乐普创一生物科技（上海）有限公司 |
抗ccr8抗体及其应用
|
|
WO2023125611A1
(zh)
|
2021-12-29 |
2023-07-06 |
四川汇宇制药股份有限公司 |
靶向cd3的抗体及多特异性抗体及其用途
|
|
TW202337912A
(zh)
|
2022-01-12 |
2023-10-01 |
美商生質分子控股有限責任公司 |
四面體抗體
|
|
CN119233997A
(zh)
|
2022-01-12 |
2024-12-31 |
生物分子控股有限责任公司 |
四面体抗体
|
|
CN116462765A
(zh)
|
2022-01-20 |
2023-07-21 |
上海君实生物医药科技股份有限公司 |
抗cd3和抗cd20双特异性抗体及其用途
|
|
CN119053342A
(zh)
|
2022-01-21 |
2024-11-29 |
礼进生物医药控股有限公司 |
用于亲合力受体交联和免疫调节的多特异性抗体
|
|
KR20230119859A
(ko)
|
2022-02-08 |
2023-08-16 |
연세대학교 산학협력단 |
신규 이중타겟 융합항체를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물
|
|
TW202400643A
(zh)
|
2022-02-28 |
2024-01-01 |
日商帝人製藥股份有限公司 |
神經退化性疾病之治療劑
|
|
GB202203070D0
(en)
|
2022-03-04 |
2022-04-20 |
Iksuda Therapeutics Ltd |
Anti-canag antibody conjugate
|
|
KR20250004952A
(ko)
|
2022-03-17 |
2025-01-08 |
씨젠 인크. |
캄프토테신 접합체
|
|
CN116789820A
(zh)
|
2022-03-18 |
2023-09-22 |
北京天诺健成医药科技有限公司 |
一种新型免疫调节剂的开发和应用
|
|
US20230414750A1
(en)
|
2022-03-23 |
2023-12-28 |
Hoffmann-La Roche Inc. |
Combination treatment of an anti-cd20/anti-cd3 bispecific antibody and chemotherapy
|
|
JP2025512798A
(ja)
|
2022-03-25 |
2025-04-22 |
サイトムエックス セラピューティクス，インク． |
活性化可能な二重アンカー型マスク化分子及びその使用方法
|
|
US20250215091A1
(en)
|
2022-03-25 |
2025-07-03 |
Les Laboratoires Servier |
Anti-GAL3 Antibodies and Compositions
|
|
KR20250006353A
(ko)
|
2022-04-04 |
2025-01-10 |
드렌 바이오, 인크. |
항-덱틴-1 항체 및 이의 사용 방법
|
|
KR20240170833A
(ko)
|
2022-04-04 |
2024-12-04 |
드렌 바이오, 인크. |
덱틴-1 및 cd20에 결합하는 다중특이성 결합 단백질 및 이의 사용 방법
|
|
AU2023248532A1
(en)
|
2022-04-08 |
2024-11-21 |
Regeneron Pharmaceuticals, Inc. |
Multipartite receptor and signaling complexes
|
|
CN118974091A
(zh)
|
2022-04-11 |
2024-11-15 |
阿斯利康(瑞典)有限公司 |
T细胞结合蛋白
|
|
WO2023198727A1
(en)
|
2022-04-13 |
2023-10-19 |
F. Hoffmann-La Roche Ag |
Pharmaceutical compositions of anti-cd20/anti-cd3 bispecific antibodies and methods of use
|
|
TW202545564A
(zh)
|
2022-04-13 |
2025-12-01 |
美商建南德克公司 |
治療性蛋白質之醫藥組成物及使用方法
|
|
AU2023253036A1
(en)
|
2022-04-15 |
2024-10-17 |
Mabsoft Therapeutics |
Conjugate comprising toll-like receptor agonist
|
|
CN117003872A
(zh)
|
2022-04-28 |
2023-11-07 |
北京天广实生物技术股份有限公司 |
含有突变轻链可变区骨架的单链抗体片段
|
|
WO2023215674A1
(en)
|
2022-05-03 |
2023-11-09 |
Xencor, Inc. |
Methods for treating lymphoma
|
|
EP4518905A1
(en)
|
2022-05-06 |
2025-03-12 |
Seagen Inc. |
Immunomodulatory antibody-drug conjugates
|
|
WO2023227660A1
(en)
|
2022-05-25 |
2023-11-30 |
Innate Pharma |
Nectin-4 binding agents
|
|
US20230416412A1
(en)
|
2022-05-31 |
2023-12-28 |
Hoffmann-La Roche Inc. |
Prevention or mitigation of t-cell engaging agent-related adverse effects
|
|
CN117323429A
(zh)
|
2022-07-01 |
2024-01-02 |
广东克冠达医药科技有限公司 |
Cd101的抗体及其用途
|
|
CN119630428A
(zh)
|
2022-07-12 |
2025-03-14 |
西托姆克斯治疗公司 |
Epcam免疫缀合物及其用途
|
|
EP4562058A4
(en)
|
2022-07-28 |
2026-08-19 |
Univ Oklahoma |
BIOMARKERS, DIAGNOSTIC METHODS, TREATMENTS AND THERAPEUTIC AGENTS FOR AUTOIMMUNE DISEASES AND DISORDERS
|
|
IL318450A
(en)
|
2022-08-03 |
2025-03-01 |
Seagen Inc |
Immunostimulatory ANTI-PD-L1-Drug conjugates
|
|
WO2024036148A1
(en)
|
2022-08-08 |
2024-02-15 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating blood cancers
|
|
EP4321522A1
(en)
|
2022-08-12 |
2024-02-14 |
Seagen Inc. |
Cytotoxic compounds and conjugates thereof
|
|
WO2024040195A1
(en)
|
2022-08-17 |
2024-02-22 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
CN117051537A
(zh)
|
2023-07-03 |
2023-11-14 |
五邑大学 |
一种乙酰化葡甘聚糖静电纺丝膜及其制备方法与应用
|